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Abstract: Splenic lesions are common in dogs and easily detected ultrasonographically, but their appear-
ance usually does not allow a definitive diagnosis. The purpose of the present study was to evaluate
ultrasonographic perfusion patterns and quantify perfusion in the normal and diseased canine spleen by
the use of a new ultrasonographic technology, contrast harmonic imaging. Of 24 dogs, 13 spleens were
considered normal and 11 spleens abnormal. Cytological or histological diagnosis was hemangiosarcoma
(n=3), hyperplasia of the lymphatic tissue (n=4), extramedullary hematopoiesis (n=1), malignant lym-
phoma (n=1) and splenic torsion (n=1). The spleen of another dog was normal sonographically; reactive
hyperplasia was found cytologically. A protocol was established for the examination of the spleens with
contrast harmonic imaging. The perfusion pattern in normal spleens was described. Benign changes
of the spleen enhanced well. In the hemangiosarcomas, enhancement was very low. In the diffuse ma-
lignant lymphoma, lesions enhanced similar to normal splenic tissue. No enhancement was seen in the
splenic torsion. Quantitative assessment of perfusion revealed similar results; however, statistical anal-
ysis was not yet significant. In conclusion, perfusion appears to differ among normal splenic tissue and
benign and malignant lesions. Contrast harmonic imaging may represent a useful non-invasive tool to
assess splenic lesions in the dog. More cases need to be investigated to prove the results of the present
study. Milzveränderungen sind bei Hunden häufig und können mit herkömmlichen Ultraschallverfahren
gut dargestellt werden. Eine definitive Diagnose kann aufgrund dieser Verfahren jedoch nicht gestellt
werden. Im Rahmen der vorliegenden Studie wurde die quantitative Durchblutung und das Durchblu-
tungsmuster der normalen und veränderten Milz des Hundes neu mit dem Contrast Harmonic Imaging
(CHI) Ultraschallverfahren evaluiert. Die Studie umfasste 24 Hunde. 13 Hunde wiesen eine normale
und 11 eine veränderte Milz auf. Zytologische oder Histologische Diagnosen der veränderten 11 Milzen
ergab Hämangiosarkom (n=3), Hyperplasie lymphatischen Gewebes (n=4), extramedulläre Hämatopoese
(n=1), malignes Lymphom (n=1), Milztorsion (n=1). Die Milz eines Hundes war sonographisch normal,
die zytologische Untersuchung ergab aber eine reaktive Hyperplasie. Die sonographische Untersuchung
der Milz mit CHI wurde protokolliert und die Durchblutungsmuster der normalen und veränderten Milz
beschrieben. Bei gutartigen Milzveränderungen wurde eine gute Kontrastmittelanreicherung angezeigt,
Hämamgiosarkome reicherten wenig und langsam Kontrastmittel an, die diffus veränderte Milz, mit
der Diagnose malignes Lymphom, zeigte eine Kontrastmittelanreicherung, welche mit der der normalen
Milz vergleichbar ist. Die Milztorsion zeigte keinerlei Anreicherung. Quantitative Auswertungen der
Durchblutung ergaben vergleichbare Resultate. Statistisch sind diese aufgrund der geringen Anzahl un-
tersuchter Fälle noch nicht relevant. Abschliessend ist zu sagen, dass sich die Durchblutungsmuster von
normalem Milzgewebe, von benigne und maligne verändertem unterscheidet. CHI könnte sich zu einem
nicht-invasiven Verfahren zur Diagnosestellung von Milzveränderungen beim Hund etablieren. Für eine
Anwendung dieses Verfahrens in der Praxis müssen noch mehr Fälle untersucht und ausgewertet werden.
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1. Summary 
Splenic lesions are common in dogs and easily detected ultrasonographically, but their 
appearance usually does not allow a definitive diagnosis. The purpose of the present study 
was to evaluate ultrasonographic perfusion patterns and quantify perfusion in the normal and 
diseased canine spleen by the use of a new ultrasonographic technology, contrast harmonic 
imaging. 
Of 24 dogs, 13 spleens were considered normal and 11 spleens abnormal. Cytological or 
histological diagnosis was hemangiosarcoma (n=3), hyperplasia of the lymphatic tissue (n=4), 
extramedullary hematopoiesis (n=1), malignant lymphoma (n=1) and splenic torsion (n=1). 
The spleen of another dog was normal sonographically; reactive hyperplasia was found 
cytologically.  
A protocol was established for the examination of the spleens with contrast harmonic 
imaging. The perfusion pattern in normal spleens was described. Benign changes of the 
spleen enhanced well. In the hemangiosarcomas, enhancement was very low. In the diffuse 
malignant lymphoma, lesions enhanced similar to normal splenic tissue. No enhancement was 
seen in the splenic torsion. Quantitative assessment of perfusion revealed similar results; 
however, statistical analysis was not yet significant. 
In conclusion, perfusion appears to differ among normal splenic tissue and benign and 
malignant lesions. Contrast harmonic imaging may represent a useful non-invasive tool to 
assess splenic lesions in the dog. More cases need to be investigated to prove the results of the 
present study. 
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2. Introduction 
2.1. Diseases of the spleen in dogs 
Morphological changes of the spleen are common in the dog. They include circumscribed 
focal masses or diffuse changes with or without overall splenic enlargement (splenomegaly). 
Splenic masses can be classified as neoplastic or non-neoplastic. Neoplastic splenic masses 
again include benign and malignant lesions (Couto and Hammer 1995). The pathological 
classification of splenic diseases in the dog is rather inconsistent in the literature. Moreover, a 
variety of terms are used interchangeably by some authors such as nodular hyperplasia, 
lymphoid hyperplasia and nodular lymphoid hyperplasia, as well as lymphoplasmocytic 
splenitis and lymphoreticular hyperplasia. However, this is in disagreement with other 
authors. The following summary is mainly based on the classification by Jubb et al. (1993) 
which includes developmental, degenerative, circulatory, inflammatory, neoplastic and benign 
hyperplastic diseases as well as hematoma, rupture, torsion and cysts (Searcy 2001, Valli 
1993). Allowance was made to important aspects of literature by other authors.  
 
2.1.1. Developmental diseases  
Developmental diseases include congenital absence, congenital ectopia, hypoplasia, shape 
anomalies, congenital or acquired accessory spleens, duplication and ectopic pancreatic tissue 
(Trautwein 1991, Valli 1993). 
 
2.1.2. Degenerative diseases 
Degenerative diseases are often seen in older dogs, such as senile atrophy of the spleen or 
siderotic nodules/plaques (Jones and others 1997, Searcy 2001, Valli 1993). The latter 
represent deposits of iron and calcium in connective tissues. The salts become encrusted and 
are of a yellowish color. In association with ceroid, these nodules likely represent the residual 
effects from areas of hemorrhage. Their deposition in the capsular margins and internally 
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suggests that a dystrophic or storage phenomenon may be more likely (Valli 1993). 
Hyperimmune states and stress may also lead to degenerative changes such as lympholysis, 
epithelioid and hypocellular appearance of the germinal centers, and a variety of vascular 
changes which may proceed to mineralization (Valli 1993). 
Amyloidosis represents a rare degenerative process in the spleen, occurring as a part of 
generalized amyloidosis. It involves the germinal centers and the enlarged and waxy follicles 
protrude from the cut-surface giving the organ the sago-spleen appearance (Searcy 2001, 
Trautwein 1991, Valli 1993). 
Hemosiderin is a storage form of iron. The amount and form of storage iron varies greatly in 
normal animals with age. Hemosiderosis represents an excessive amount of hemosiderin due 
to hemolytic anemia causing tissue injury and fibrosis. Rare storage diseases of the spleen 
have been described in the dog such as sphingomyelin storage in the nervous system and the 
spleen (Searcy 2001, Trautwein 1991, Valli 1993). 
 
2.1.3. Circulatory disorders 
There are various circulatory disorders that cause splenomegaly. Passive congestion occurs 
most commonly due to the use of barbiturate drugs or acepromazine which cause relaxation of 
the smooth muscle of the splenic capsule. With propofol, no enlargement was found in a 
recent study (O'Brien and others 2004b). Cardiac, pulmonary or portal venous congestion 
does not appear to be as common as in humans causing congestion of the spleen in the dog. 
This may be due to the highly muscular capsule which is not easily distended (Valli 1993), or 
due to the development of velar-omental veins that decompress the spleen by shunting blood 
to the left renal vein (Couto and Hammer 1995). Torsion of the spleen either isolated or in 
association with the gastric dilatation-volvulus syndrome, commonly results in a marked 
splenomegaly caused by congestion due to occlusion of the splenic vein. Ultimately, 
occlusion of the arteries occurs, resulting in ischemia, which is followed by hemolysis and 
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diffusion of hemoglobin through the devitalized splenic capsule. This process results in 
hemoglobinemia and hemoglobinuria (Searcy 2001, Valli 1993). Most often affected are dogs 
of large, deep-chested breeds. Clinical signs can be either acute or chronic. 
Thrombosis of the splenic vein has been observed in association with splenic congestion of 
any cause, hypercoagulable states and hyperviscosity syndrome (Couto and Hammer 1995). 
Embolism with infarction is also not uncommon, is mainly seen in the splenic artery and 
usually derives from valvular vegetations (Couto and Hammer 1995, Valli 1993). 
Active hyperemia may be seen with acute systemic infections (Valli 1993). 
 
2.1.4. Inflammatory changes 
Inflammatory changes within the spleen usually result in diffuse enlargement of this organ. 
Most disorders associated with splenitis are infectious in nature. In addition to 
lymphoreticular hyperplasia, splenic changes in splenitis include hematogenous infiltration 
with inflammatory cells. According to the course of the disease, splenitis can be classified as 
either acute, subacute, or chronic; according to the predominant cell type, they can be 
classified as suppurative (predominant cell type: the neutrophil), necrotizing (necrosis 
predominates), eosinophilic (eosinophils predominate), lymphoplasmocytic (lymphocytes and 
plasma cells predominate), granulomatous (macrophages, epithelioid cells, lymphocytes, or 
multinucleated giant cells predominate), and pyogranulomatous (granulomatous changes and 
neutrophilic infiltration are present) (Searcy 2001). The terms lymphoplasmocytic splenitis 
and lymphoreticular hyperplasia are frequently used interchangeably. It is important to 
classify the splenitis according to the predominant cell type, since different etiologic agents 
are associated with the different forms. Diseases associated with suppurative splenitis include 
penetrating wounds, migrating foreign bodies, hematogenous dissemination of bacterial 
infections, bacterial infections secondary due to splenic torsion, protozoal infections 
(toxoplasmosis), and certain viral diseases. If cavitated lesions form with suppurative 
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splenitis, the term splenic abscess is preferred. Necrotizing splenitis may be caused by gas-
forming anaerobes, seen with splenic torsion and neoplasia e.g. lymphoma, hemangiosarcoma 
or histiocytic sarcoma. 
Eosinophilic infiltrates have been observed with eosinophilic gastroenteritis in the dog. 
Lymphoplasmocytic splenitis occurs in association with subacute or chronic infectious 
disorders. Granulomatous splenitis occurs in some systemic mycosis and mycobacterial 
infections (Searcy 2001). 
 
2.1.5. Benign hyperplastic diseases 
Benign hyperplastic changes of the spleen are composed of cells normally found in the canine 
splenic parenchyma (Spangler and Kass 1998). Nodular hyperplasia is frequently observed in 
the spleen of old dogs; together with splenic hematomas, they made up most of the splenic 
lesions in a very large study group (Spangler and Culbertson 1992). Hyperplastic nodules lack 
a capsule and germinal centers, consisting of monomorphic medium or large lymphocytes 
with moderate cytoplasmic volume and small nucleoli. There may be many mitoses, and the 
lesions are judged to be benign more on knowledge of behavior than cytology. There is no 
evidence to suggest that these lesions ever progress to lymphoma (Valli 1993). Microscopic 
examination of splenic nodular hyperplastic lesions often reveals varying and sometimes 
complex cellular composition. These nodules can thus be grouped into distinct morphologic 
categories based on the relative proportion and type of cellular components that make up the 
nodule (i.e. lymphoid, hematopoietic, plasmacytic, or mixed) (Spangler and Kass 1998). 
Splenic plasmacytoma is a rare condition in dogs. Cytologically, the cells are uniform and of 
moderate size but with abundant, usually eccentric cytoplasm. Nucleoli are small but 
prominent and central, and there is mild heterochromatin aggregation. Mitoses are less 
numerous than in the normal surrounding tissue. Plasmacytoma may progress to an 
immunoblastic type of lymphoma within a year of biopsy (Valli 1993). 
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Hematopoietic alterations include extramedullary hematopoiesis, myeloid metaplasia, 
myelolipoma, and lymphoid hyperplasia (Valli 1993). Extramedullary hematopoiesis is 
common in dogs. The spleen retains its fetal hematopoietic potential during adult life. A 
variety of causes may stimulate the spleen’s fetal hematopoietic function and producing red 
blood cells, white blood cells, and platelets (Searcy 2001). Megakaryocytes are the most 
obvious hematopoietic precursors and characteristically lie adjacent to the smooth muscle 
trabeculae when stimulation is mild, but may become diffusely distributed in the sinus areas 
when stimulation is prolonged and pronounced. In contrast, myeloid metaplasia is a condition 
where there is diffuse hematopoiesis in the spleen without an apparent target for the increased 
cell production (Spangler and Kass 1999, Valli 1993).  
Myelolipomas are composed of normal marrow with about 50% hematopoietic and the rest, 
large typical fat cells (Valli 1993). 
Lymphoid hyperplasia of the spleen occurs by expansion of the periarteriolar lymphoid 
sheaths (Valli 1993). 
In the present study, the term reactive hyperplasia is also used. The clinical pathologists at our 
faculty preferably use it to describe reaction of the white pulp with an increased number of 
medium-sized to large lymphocytes and plasma cells. If the extent of reactive hyperplasia is 
less than 10%, then it may be considered normal splenic tissue.  
Hyperplastic nodules of the spleen also include a distinct population of spindle and/or 
histiocytic cells (fibrohistiocytic cells) that in some cases displace or distort the lymphoid 
follicular architecture of the nodule. This type of nodule seems to represent the benign limit of 
a continuum between nodular hyperplastic proliferation in the splenic parenchyma and 
nodular neoplasms consisting of pleocellular components (malignant fibrous histiocytoma). 
However, malignant fibrous histiocytoma exhibits a broad range of biological behavior 
(Spangler and Kass 1998). 
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2.1.6. Hematoma 
Splenic hematomas are very common in dogs, and the cause is often not obvious. They may 
occur secondary to trauma. Most dogs are relatively healthy (Searcy 2001). However, they 
may also undergo spontaneous splenic rupture and hemoabdomen (Prymak and others 1988). 
One report describes the relation of splenic hyperplastic nodules and splenic hematomas in a 
very large group of samples. The authors observed superimposition of nodular lymphoid 
elements with hematomas. They suggest that with nodular lymphoid hyperplasia, marginal 
zone distortion with regional disruption of splenic blood flow is seen, leading to failure of 
marginal zone circulation and accumulation of blood within and around the hyperplastic 
nodule. Eventually, this causes hematoma formation, hypoxia and necrosis (Spangler and 
Culbertson 1992). Splenic hematomas may also be associated with neoplastic lesions such as 
hemangiomas, hemangiosarcomas or lymphomas (Jones and others 1997).  
 
2.1.7. Rupture 
Rupture of the spleen is not uncommon in the dog and caused by a major trauma such as a car 
accident. Bleeding to a various degree is found and fragmentation of the spleen may be seen. 
Neoplastic diseases such as hemangiosarcoma or lymphosarcoma may also lead to rupture of 
the capsule and exsanguination. Pathologic rupture of the spleen may also occur with 
congestive, hemolytic or infectious diseases (Jones and others 1997, Valli 1993).  
 
2.1.8. Cysts 
Splenic cysts are unusual and they may occur in conjunction with infection with 
Echinococcus species, cystic degeneration of hematomas, or neoplastic cysts such as 
hemangiomas or hemangiosarcomas (Jones and others 1997, Valli 1993). 
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2.1.9. Neoplastic diseases 
Neoplastic splenic masses include benign and malignant lesions and are represented mainly 
by endothelial tumors, namely hemangiomas and hemangiosarcomas. Other neoplasms that 
may present as splenic masses in dogs are fibrosarcomas, leiomyosarcomas, leiomyomas, 
malignant fibrous histiocytomas, malignant histiocytosis, lymphomas and mesotheliomas 
(Couto and Hammer 1995, Cruz-Arambulo and others 2004, Searcy 2001, Spangler and Kass 
1998). It appears that splenic masses are more common than diffuse splenic enlargement in 
dogs, whereas the opposite occurs in cats (Searcy 2001). Neither the size nor the gross 
appearance of splenic masses can be used as a guide to determine their biological behavior. It 
is not uncommon to observe extremely large hematomas whereas hemangiosarcomas may be 
small. Moreover, hepatic extramedullary hematopoiesis or regenerative hepatocellular 
hyperplasia may result in the appearance of hepatic masses that mimic metastatic lesions, 
even in dogs with splenic hematomas (Couto and Hammer 1995).   
Generalized enlargement of the spleen with diffuse infiltration with neoplastic cells is a 
common finding in dogs with lymphoma, mastocytosis, malignant histiocytosis, multiple 
myeloma, and is rarely seen with splenic metastases from mammary adenocarcinomas and 
intra-abdominal (e.g. pancreatic) carcinomas (Couto and Hammer 1995). Splenic metastases 
may also appear as focal masses.  
Hemangiosarcomas appear to be extremely common in dogs and represent the most frequent 
neoplasm of the canine spleen (Spangler and Culbertson 1992). However, the same authors 
found that the combined prevalence of all other splenic neoplasms (nonangiomatous and 
nonlymphomatous) was similar to that of the hemangiosarcoma alone. Hemangiosarcomas 
occur predominantly in older large-breed dogs, and there is a predilection for males and for 
German shepherd dogs as well as for Golden Retrievers. Clinical sings and physical findings 
in dogs with splenic hemangiosarcomas are usually vague and non-specific. They include 
anorexia, weight loss, abdominal distension, weakness, pallor and vomiting. A large majority 
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of dogs with hemangiosarcomas are examined because of rupture of the primary tumor 
(Couto and Hammer 1995). Hemangiosarcomas have aggressive biological behavior. More 
than 50% of the affected dogs have gross evidence of metastatic disease on initial presentation 
which is usually found in the liver, omentum, peritoneum, kidneys, heart and lungs (Couto 
and Hammer 1995). Surgical resection has been the mainstay of therapy in dogs with splenic 
hemangiosarcoma. In one study, splenectomy in dogs with hemangiosarcoma resulted in a 
median survival of 65 days (mean 80 days). Depending on the protocol, median survival may 
be improved as a result of chemo- or immunotherapy (Couto and Hammer 1995).  
Compared to hemangiosarcomas, hemangiomas behave biologically not aggressive. They are 
not as common and depending on the study, they represent 1-10% of splenic masses. Most 
dogs with splenic hemangiomas are clinically healthy and rupture with abdominal bleeding is 
rarely seen (Couto and Hammer 1995, Searcy 2001). 
Malignant histiocytosis is characterized by malignant histiocytes, which have marked cellular 
atypia. Another common finding is the presence of bizarre multinucleated giant cells (Vail 
2001). Malignant fibrous histiocytoma is characterized by cells with variable fibroblastic to 
less obviously histiocytic cells and associated variable numbers of nonneoplastic 
inflammatory cells (Hayden and others 1993, Kerlin and Hendrick 1996). Some histiocytic 
neoplasms have characteristics of both malignant histiocytosis and malignant fibrous 
histiocytoma. These neoplasms have been defined as histiocytic sarcomas. In the dog they 
include tumors of macrophage and tumors of dendritic cell origin which resemble dendritic 
cell sarcomas described in humans. Such tumors are rapidly growing and locally aggressive. 
The prognosis, despite treatment, is poor with an average survival time of 5.3 months and a 
high metastasis rate (Craig and others 2002). Malignant histiocytosis and malignant fibrous 
histiocytoma most commonly affect the lung, the hilar lymph nodes, the mesenteric lymph 
nodes, the liver and the spleen. Bernese mountain dog, Golden Retriever, Rottweiler, and 
Doberman pinscher breeds have been reported to be at higher risk for malignant histiocytosis, 
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whereas malignant fibrous histiocytoma has been reported most commonly in Golden 
Retrievers. The etiology of malignant histiocytosis is unknown. However, familial occurrence 
has been reported in Bernese mountain dogs, suggesting the possibility of a genetic 
predisposition. Prognosis is grave and response to combination chemotherapy has been 
generally unrewarding, at best resulting in short-term palliation (Vail 2001).  
 
2.2. Diagnosis of splenic diseases in dogs 
During a routine physical examination, the spleen can be palpated in the dog as a flat structure 
oriented dorsoventrally in the left anterior abdominal quadrant. However, it has to be 
emphasized that palpably enlarged spleens are not always abnormal, and that enlarged spleens 
are not always palpable. Clinical and physical signs of dogs with a focal or generalized 
enlarged spleen are usually vague and nonspecific. With the exception of splenic torsion, they 
are in general related to the primary disease rather than to splenic enlargement per se (Couto 
and Hammer 1995).  
 
2.2.1. Radiographic imaging 
The spleen is normally well visualized on abdominal radiographs, but there is a wide variation 
in its appearance. Radiographically, the spleen is an elongated, flat, solid organ in the cranial 
left abdomen, lying just caudal to the stomach. The dorsal extremity of the spleen (head) is 
less variable in its position because of the short gastrosplenic ligament and its location 
between the gastric fundus and the cranial pole of the left kidney. There, the head is seen as a 
triangular structure. The ventral extremity is less tightly fixed in position and thus may vary 
greatly in location. Because determination of normal splenic size is subjective, alterations in 
the size of this organ must be substantial to be recognized. The spleen may increase in size 
uniformly and diffusely, or the spleen may enlarge locally, as with a splenic mass, with or 
without alteration in the splenic shape and margination. Gas accumulation in the splenic pulp 
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is seen rarely and may be associated with necrosis, splenic torsion and proliferation of gas-
forming organisms (Pechman 1998).  
 
2.2.2. Ultrasonographic imaging 
The size of the spleen is variable and must be assessed subjectively, similar to radiography. 
The capsule is smooth, regular and echogenic when the beam strikes it perpendicularly. With 
splenic masses, the capsule is interrupted or deviates outward, and the splenic parenchyma is 
continuous with the mass. The normal splenic parenchyma is homogeneous with a finely 
textured, medium to high level echo pattern. This pattern contrasts with the coarse slightly 
less echogenic appearance of the liver. The spleen is normally considerably more echogenic 
than the cortex of the left kidney. The splenic arterial branches are difficult to see on routine 
splenic scans. Doppler ultrasonography can help determine their location. The branches of the 
splenic vein are easily detected near the hilus of the spleen, but their course into the splenic 
parenchyma can be followed only for a short distance in the normal animal. The size of the 
splenic veins must be judged subjectively. The main splenic vein can usually be traced from 
the spleen to the main portal vein. The splenic hilar region should always be carefully 
searched for lymphadenopathy (Nyland and others 2002a).  
With diffuse splenic diseases (infectious, inflammatory, non-neoplastic/non-inflammatory, 
benign or malignant neoplastic), hypo-, hyperechogenicity or normal echogenicity may be 
seen in combination with or without diffuse splenomegaly. Ultrasonography is not helpful in 
establishing a specific diagnosis and the differential diagnosis list is long. Therefore, a biopsy 
is usually indicated unless the diagnosis is obvious from other clinical information (Nyland 
and others 2002a). In a recent study it was not only shown that significant enlargement of the 
spleen occurs due to the use of barbiturate drugs or acepromazine, but attenuation and 
backscatter was also markedly increased after the administration of acepromazine. With 
propofol, no enlargement was found (O'Brien and others 2004b). 
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Splenic torsion produces a markedly enlarged spleen with diffuse anechoic areas (lacy 
pattern) and multiple parallel echogenic lines within the parenchyma. The anechoic areas are 
thought to represent dilated sinusoids from splenic congestion, whereas the parallel echogenic 
lines are thought to be severely dilated vessels. A lacy pattern without dilated vessels (parallel 
echogenic lines) may also be seen with acute splenitis, necrosis and infarction from other 
causes than torsion (Mai 2006, Nyland and others 2002a). The splenic veins near the hilus are 
also enlarged from venous outflow obstruction. Infarction, necrosis, abscess formation, 
thrombus formation in the splenic veins or free abdominal fluid may be seen. Doppler 
evaluation of the splenic veins indicates an absence of blood flow. Arterial flow may or may 
not be present, depending on the degree of torsion (Saunders and others 1998). However, 
absence of flow might also be due to splenic vein thrombosis, even when intraluminal echoes 
cannot be identified (Mai 2006). The presence of a hilar hyperechoic perivenous triangle was 
significantly associated with splenic torsion in a recent study. This sign was continuous with 
the hyperechoic mesentery and although not being pathognomonic, it may be associated with 
acute splenic torsion because of the secondary severe diffuse splenic enlargement (Mai 2006). 
Focal lesions of the spleen are easily detected, but the ultrasound appearance usually does not 
allow a definitive diagnosis. Hyperplastic nodules, hematoma, abscess, primary or metastatic 
neoplasia, necrosis from vascular compromise, toxic conditions and inflammatory disorders 
can produce similar ultrasound findings. Depending on its age, a hematoma is extremely 
variable. Intraparenchymal hemorrhage may initially appear hyperechoic but larger 
collections of unclotted blood are initially hypoechoic to anechoic. Clotted blood may appear 
iso- to hyperechoic. A cystlike structure may develop as the clot organizes. Hematomas and 
infarcts generally get smaller over time. Infarcts may show a hypoechoic, wedge-shaped 
appearance with the base towards the splenic margin. However, they may also appear poorly 
marginated, circular in shape or as complex lesions. An abscess is likely if intense areas of 
hyperechogenicity with dirty shadowing are present within the lesion because of gas-forming 
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microorganisms. Hyperplastic nodules are not always observed ultrasonographically. They 
may only alter the otherwise smooth margin of the spleen, may be iso- to hypo- or even 
hyperechoic in comparison to the normal spleen or may even have a complex appearance. The 
type of malignant splenic neoplasia can neither be determined from its ultrasonographic 
appearance. Even cavitated lesions are not pathognomonic of hemangiosarcoma (Nyland and 
others 2002a).  
 
2.2.3. Computed tomography and magnetic resonance imaging 
In humans, ultrasound largely has been replaced by computed tomography (CT) and magnetic 
resonance imaging (MRI) for the characterization of focal hepatic and splenic lesions. So far, 
there are only two reports in the literature describing the use of CT and MRI for the diagnosis 
of splenic lesions in the dog. 
In a recent study, the authors investigated the use of CT for the differentiation of splenic 
masses (Fife and others 2004). Malignant splenic masses had significantly lower attenuation 
values measured in Hounsfield units, than non-malignant splenic masses, on both pre- and 
post contrast images. On post-contrast images, there was a significant difference in 
attenuation characteristics among the three subset of masses (malignant, hematoma, 
hyperplasia), with nodular hyperplasia having the highest Hounsfield units, hematomas 
having intermediate Hounsfield units, and malignant masses having the lowest Hounsfield 
units values. A receiver operator characteristic curve of post-contrast medium Hounsfield 
units revealed 55 as the best threshold value to distinguish malignant from nonmalignant 
masses, with those less than the threshold value being malignant. The authors suggested that 
the low Hounsfield units for the hemangiosarcomas were due to the formation of large 
hematocysts or blood-filled cavities. The high degree of contrast enhancement of the 
hyperplastic nodules may have been related to the high degree of vascularity of hyperplastic 
lymphoid tissue. The underlying etiology of splenic hematomas in the dog was thought to 
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explain the intermediate degree of contrast enhancement. In contrast to humans, splenic 
hematomas in the dog are often secondary to a primary disorder such as nodular hyperplasia. 
None of the dogs in their study had a history of trauma. However, the malignant masses in 
that study mainly included hemangiosarcomas and only one fibrosarcoma and one malignant 
fibrous histiocytoma. The nonmalignant group included dogs with splenic hematoma, nodular 
hyperplasia and one nonmalignant fibrohistiocytic nodule (Fife and others 2004). 
In human patients, the inherently high soft tissue contrast of MRI allows the differentiation of 
benign and malignant hepatic and splenic lesions. In a recent study in dogs, a MRI 
classification system similar to humans was used successfully on the basis of lesion signal 
characteristics to differentiate malignant from benign splenic lesions in dogs. Malignant 
lesions showed very similar imaging characteristics in both humans and dogs (Clifford and 
others 2004). 
 
2.2.4. Cytology and histology 
The spleen is easily accessible with ultrasound and ultrasound-guided biopsies are easily 
performed. Aspiration procedures are most useful in detecting lymphoma or mast cell 
involvement. Tissue-core biopsies have been avoided because of a high potential for 
hemorrhage although some authors reported a lower complication rate and conclude that 
tissue-core biopsies of solid splenic masses are useful and can be performed safely. Lower 
quality samples may be attributed to red pulp congestion because of anesthesia or 
engorgement of the spleen. Aspirates and tissue-core biopsy specimens of complex splenic 
masses primarily containing fluid-filled cystic structures (e.g. hemangiosarcomas) are less 
useful and often non-diagnostic because of blood dilution (Nyland and others 2002b). 
Therefore, a negative aspirate does not rule out neoplasia. Moreover, repeated hemorrhages, 
necrosis, and organization may make hemangiosarcomas difficult to distinguish from 
longstanding infarction of the spleen or hematomas (Nyland and others 2002a). The critical 
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item in the diagnosis of hemangiosarcoma is the presence of typical vascular-forming 
malignant endothelial cells (Jones and others 1997).  
 
2.3. Contrast harmonic imaging 
The concept of contrast imaging was introduced to ultrasound almost 30 years ago. It was first 
observed in echocardiography, rather incidentally, when small air bubbles were noted 
surrounding a catheter tip placed in the left ventricle during cardiac catheterization producing 
transient high reflections (Gramiak and Shah 1968). From that time on, intensive research was 
dedicated to the development of clinically relevant ultrasound contrast agents. Technical 
developments enabled the production of microbubbles that are stable in the circulation, 
traverse the pulmonary circulation to allow recirculation, and are inert to the patient. These 
dramatic improvements in ultrasound contrast agent persistence and efficacy have led to the 
extended usefulness of ultrasound imaging in human medicine and clinical research. 
Similarly, the advent of microbubble contrast agents has encouraged the development of new 
ultrasound technologies such as specific contrast imaging sequences. These developments 
have brought new possibilities such as assessment of tissue perfusion into clinical application 
and research. 
 
2.3.1. Properties of ultrasound contrast agents 
An ultrasound contrast agent is an exogenous substance, consisting of gas or air microbubbles 
encapsulated by a shell of different composition, that can be administered intravenously or 
into a body cavity to enhance ultrasonic signals. Commercially available microbubble contrast 
agents are approximately 2-6 µm in diameter; they are much smaller than the wavelength of 
the ultrasound beam (approximately 0.5 mm in water at 3 MHz) and therefore, behave as 
scattering reflectors. Because gases have acoustic impedance very different from blood and 
tissue, microbubble contrast agents have a good scattering yield (Dalla Palma and Bertolotto 
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1999). Although highly reflective, these agents also are highly attenuating at fundamental 
frequencies, causing severe loss of signal strength as the sounds travels through the enhanced 
portions of the body. Various studies have documented the unacceptably high attenuation 
coefficient which is directly frequency-dependent at fundamental transmitted frequencies 
(Couture and others 2006). 
Most ultrasound contrast agents do not diffuse across the endothelium and therefore, they 
basically are blood pool agents. Vascular enhancement usually lasts a few minutes. Typically, 
the gas content of the contrast agent is eliminated via the lungs, while the shell components 
are filtered by the kidney and eliminated by the liver (Quaia 2005a). 
Some agents have additional tissue specific properties. After blood pool clearance, Levovist 
has been shown to have a late hepatosplenic-specific parenchymal phase with accumulation in 
the human liver and spleen up to 20 min after intrvenous bolus injection. The underlying 
mechanism is not fully understood; accumulation may be mediated by the reticuloendothelial 
system, e.g. the Kupffer cells, or microbubbles are entrapped in the liver sinusoids (Quaia 
2005a). Therefore, the late phase is also called sinusoidal phase. Other agents such as 
SonoVue or Imavist, although primarily designed as blood pool agents, were also 
subsequently found to have the sinusoidal phase because the agents are believed to be trapped 
or slowed in the hepatic sinusoids (Leen and Horgan 2003). Another study reported spleen-
specific parenchymal uptake of SonoVue in humans (Lim and others 2004). 
 
2.3.2. Principles of action 
The behavior of the microbubble under ultrasound beam is governed by parameters such as 
resonance frequency, pulse repetition frequency, number and location of focal zones, acoustic 
power, the filling gas, damping coefficients and shell properties. Beside the other factors, the 
local acoustic power is the principal parameter affecting microbubble behavior (Quaia 
2005b). The local acoustic power depends on the output power of the ultrasound system, the 
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transmit frequency and the attenuation of the ultrasound beam with depth (Correas and others 
2001). The output power is reflected by the mechanical index (MI) which originally measures 
the potential for mechanical damage to tissues exposed to intense ultrasound pulses. The MI 
also gives an indication of the likelihood of bubble destruction: the higher the MI, the greater 
its destructive properties (Averkiou and others 2003, Quaia 2005b). In clinical practice, the 
range for MI varies from 0.05 to 1.9. However, with the same MI the acoustic power may 
vary in different ultrasound systems (Quaia 2005b). Depending on the acoustic power, 
different interactions between the incident ultrasound beam and the microbubbles take place 
such as scattering, resonance and microbubble destruction. 
Linear behavior of microbubbles - With very low acoustic power (MI <0.1), the microbubble 
radius does not change significantly over time and the bubble can be considered a static 
object. The scattering intensity increases with the intensity and the frequency of the incident 
ultrasound beam, and the number and radius of the microbubbles (Dalla Palma and Bertolotto 
1999).  
Resonance is another scattering mechanism observed at slightly greater acoustic power. 
Microbubbles respond to the positive and negative pressures of the sinusoidal sound wave by 
oscillation, changing their radius with time (contraction and expansion). At a particular 
frequency called fundamental or resonance frequency, these oscillations become resonant. 
The microbubbles oscillate synchronously with the incident ultrasound wave (Correas and 
others 2001, Leen and Horgan 2003). Since ultrasound contrast agents have microbubbles 
with a large size distribution, resonance does not occur at a single frequency but at a 
frequency range. Fortunately, the resonance frequency of microbubbles lies within the 2-15 
MHz range, most frequently used for clinical diagnosis. Oscillation increases the scattering 
intensity because the average bubble’s size is greater over time (Calliada and others 1998, 
Dalla Palma and Bertolotto 1999).  
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The linear effects of ultrasound contrast agents are utilized in the clinical setting by Doppler 
technologies, but rarely with grey-scale sonography because of the high attenuation 
coefficient. The signal to noise ratio drops rapidly with depth in the enhanced organ. Until 
recent advances in pulse sequence technology, discussed below, imaging of contrast agents 
for detecting tissue perfusion made use of exclusively the nonlinear effects. 
Non-linear behavior of microbubbles - If the acoustic power of the ultrasound beam at the 
resonance frequency increases (intermediate MI: 0.1 < MI > 0.5), the microbubbles will show 
a longer expansion than contraction phase and begin non-linear (non-sigmoidal shaped) 
oscillation (Correas and others 2001, Quaia 2005b). They start to emit the harmonics of the 
resonance frequency. The frequency of subharmonics is at half and that of higher harmonics 
is at multiples of the fundamental frequency. The second harmonic response is found at twice 
the fundamental frequency and usually has the highest intensity of the harmonic responses 
(Correas and others 2001). The theoretical advantage of the harmonic over the fundamental 
frequency is that only microbubbles resonate with harmonics while adjacent tissues do not 
resonate or their harmonic resonation is very little (Calliada and others 1998). 
With further increase of the intensity of the ultrasound beam (high MI: MI > 0.5), the shell of 
microbubbles is disrupted and a transient strong non-linear echo is emitted (Correas and 
others 2001, Dalla Palma and Bertolotto 1999). This destruction modality is called stimulated 
acoustic emission or loss of correlation.  
 
2.3.3. Classification of ultrasound contrast agents 
Ultrasound contrast agents are grouped into 4 classes or generations (Bauer and Solbiati 
2003). Several agents have been approved for the clinical use in humans. Although the 
approved indications are restricted, ultrasound contrast agents have also been used and tested 
widely for off-label indications in humans. So far, no contrast agent has been approved for 
veterinary use. In the present section, the most common ultrasound contrast agents are 
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discussed. It has to be mentioned though, that many more interesting ultrasound contrast 
agents are still in the phase of comprehensive testing and development. 
At the beginning, contrast agents were hand-made, simply by agitating physiological saline 
solution prior to injection. In this way, free air microbubbles are produced and they represent 
the first class of contrast agents; however, because of their large size (>50 µm), they do not 
pass the capillary bed of the lungs. This hand-made agent is suitable for diagnosing an intra- 
or extracardiac right-to left shunt and is still used in veterinary echocardiography today 
(Kienle and Thomas 2002). 
Microbubble persistence and stability was increased by two principal ways: bubble 
encapsulation with or without surfactants and selection of gases with low diffusion 
coefficient. This has led to the development of the first generation of transpulmonary contrast 
agents using air as the gas in the microbubbles covered by a shell. One of the most intensively 
investigated first generation ultrasound contrast agents is Levovist (Quaia 2005a). It is 
characterized by air microbubbles with a mean diameter of 2-3 µm covered by a galactose and 
palmitic acid shell. The shell provides increased microbubble stability and allows 
recirculation and capillary passage. Systemic enhancement of Doppler signals is produced 
over 1-5 min after i.v. bolus injection. After blood pool clearance, Levovist has been shown to 
have a late hepatosplenic-specific parenchymal phase with accumulation in the human liver 
and spleen up to 20 min after i.v. bolus injection (Quaia 2005b). Levovist only produces a 
clinically useful signal at medium to high acoustic pressure, and is simultaneously destroyed. 
The second generation of ultrasound contrast agents uses insoluble gases to achieve better 
stabilization and lower diffusion of the microbubbles (Bauer and Solbiati 2003, Quaia 2005a). 
This increases survival of the microbubbles and therefore, the diagnostic window. Their half-
life is longer than 5 min after intravenous bolus injection. One group of second generation 
ultrasound contrast agents is composed of perfluorocarbon-filled microbubbles, e.g. Definity, 
Imagent and Optison. Perfluorochemicals are inert compounds, which are immiscible with 
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water and can be injected intravenously if emulsified. Whereas Definity and Imagent have a 
phospholipid shell, Optison has a human albumin shell. 
Another group of second generation ultrasound contrast agents is composed of sulphur 
hexafluoride-filled microbubbles, e.g. SonoVue. The advantages of sulphur hexafluoride-
filled microbubbles are the prolonged stability in the vial (up to 6 hours) and the peripheral 
blood (half-life of 6 min), and the uniformity of their size, which improves backscattering and 
harmonic behavior at low acoustic power (Quaia 2005a). Similar to Levovist, SonoVue has 
also been shown to have a late hepatosplenic-specific parenchymal phase in humans (Leen 
and Horgan 2003, Lim and others 2004). SonoVue provides a non-linear response with 
production of a clinically useful signal at low acoustic pressures, and destruction of the 
microbubbles is limited. 
Third generation agents use the stabilization of a hard shell (polymer shells) and contain 
either air or perfluorocarbons, resulting in a much longer persistence time (Leen and Horgan 
2003). 
 
2.3.4. Safety considerations 
In general, ultrasound contrast agents are extremely safe and well tolerated. Guidelines for 
their clinical use in humans were published by the European Federation of Societies for 
Ultrasound in Medicine and Biology (Albrecht and others 2004). In humans, the incidence of 
side effects is low, predominantly minor in nature (headache, nausea) and self-limiting. 
Hypersensitivity or allergic events occur rarely. There is no evidence of nephrotoxicity or 
cardiotoxicity. However, there is the possibility of bioeffects such as microvascular rupture 
with the insonation of microbubbles. Therefore, caution is suggested when imaging the retina 
or the brain through the open fontanella. Further, premature ventricular contractions may 
occur when high mechanical index end systolic triggering is used in echocardiography but not 
with other applications. In general, long examination times and the use of contrast agents 
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within 24 hrs prior to extra-corporal shock wave therapy should be avoided. So far, no side 
effects have been reported with the use of Definity, Imagent, SonoVue and Levovist in dogs 
and cats (Nyman and others 2005, O'Brien and others 2004a, Rademacher and others 2005, 
Schärz and others 2005). Immune reactions have not been associated with the use of Optison 
in humans. Although there are reports of uncomplicated use of Optison in dogs and other 
small animals (Mattoon and others 2002), anaphylactic response related to the human albumin 
component has been reported in two dogs (Yamaya and others 2004). Severe but self-limited 
hypotension was observed, and the authors suggested mechanical ventilation and availability 
of emergency agents. Due to these complications and safer alternative contrast media, the use 
of Optison is considered contraindicated for clinical use in veterinary patients. 
 
2.3.5. Imaging techniques 
Imaging of contrast agents is more complex than mere addition of contrast media to 
conventional grey-scale and Doppler sequences. Manufacturers have long realized that bubble 
contrast agents are especially sensitive to the local deposition of sound energy. Sufficient 
energy (sound amplitude) must be provided to generate an adequate signal-to-noise ratio for 
agent detection, but not so high that bubble destruction occurs preventing real-time display of 
perfusion. This careful of energy balance includes adjustment of MI (output power), frame 
rate, number and location of focal zones, and transmitted frequency. Included in the pulse 
sequence adjustments are specific optimization of grey scale maps, frame averaging and edge 
enhancement. Technologies now exist to image contrast agents in both the fundamental (1st 
harmonic) and harmonic (2nd harmonic) frequencies by differing applications and 
manufacturers.  
Fundamental imaging techniques - Ultrasound contrast agents can be used with conventional 
B-mode and Doppler sonography. Contrast agents cause significant enhancement of Doppler 
signals and have been used for many years for vascular studies. All conventional Doppler 
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modalities including color, power and spectral Doppler imaging, are very sensitive to the 
presence of microbubbles. Fundamental Doppler modes commonly use the stimulated 
acoustic emission modality with high MI settings. The contrast agent increases the Doppler 
signal, thereby increasing the sensitivity for low flow situations and detection of small vessels 
(Dalla Palma and others 1999). Conventional contrast-enhanced power Doppler ultrasound 
has been shown to be more sensitive for detecting low velocities and small parenchymal 
vessels than power Doppler alone or color Doppler with or without the use of a microbubble 
contrast agent (Bude and others 1994, Eriksson and others 1991). While color Doppler 
displays the change in the returning frequency to provide velocity and directional information, 
power Doppler records the amplitude (energy) of the reflected Doppler signal from moving 
blood cells. Color brightness is related to the number of moving cells, not the velocity. 
Because of the lack of angle dependence and the very low energy of random noise, higher 
gain settings may be used with power Doppler which increases sensitivity for flow detection 
(Rubin 1999). However, many imaging artifacts reduce the clinical benefits of contrast-
enhanced Doppler ultrasound. These include high-intensity transient signals (flash), pseudo 
acceleration of the peak systolic velocity and blooming. To avoid interpretative errors, 
artifacts need to be recognized and the following settings should be adapted; reduction of 
color gain, persistence and MI, slower infusion of contrast agent, and increasing the wall filter 
and pulse repetition frequency (Quaia 2005b). Contrast-enhanced Doppler ultrasound is very 
sensitive to motion artifacts and is limited to the evaluation of more superficial structures or 
body regions less susceptible to respiratory and cardiac motions. 
Grey-scale imaging in the fundamental (=transmitted) frequency of contrast agents has been 
historically limited for a number of reasons. Large dosages (0.08 ml/kg) of a second 
generation contrast agent (Imagent) were required for enhancement of vessels against the 
echogenicity of normal tissues (Bahr and others 2000). Little true perfusion imaging was 
achieved at these high dosages and the attenuation effects exceeded the enhancement benefits. 
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Contrast pulse sequence (CPS) is a new technology that processes the unique nonlinear 
fundamental and higher order harmonic signal (Phillips and Gardner 2004). By varying the 
phase and amplitude of multiple pulse interactions the contrast agent signal can be separated 
from the tissue signals. Because the effects of phase and amplitude on contrast agents are less 
frequency dependent than harmonic techniques, imaging is possible with higher frequency 
transducers (Cosgrove 2004). This allows more superficial structures or smaller patients, 
including smaller research rodents, to be imaged without loss of resolution inherent with the 
use of low frequency transducers in harmonic technologies. This CPS proprietary technology 
seems to hold great clinical and research promise. 
Harmonic imaging techniques - Most of the commercial pulse sequence technologies have 
utilized the powerful emission of second-order harmonics for detection of contrast agents and, 
therefore, patterns of perfusion. As previously noted, contrast agents produce a 
disproportionately large amount of harmonic signal when insonated with frequencies 
approximating the resonant frequency. The most basic method for isolating the harmonic 
component is by filtering the returning signal (Correas and others 2001). Subtracting the 
fundamental (= transmitted bandwidth) portion from the returning signal should result in only 
the harmonic component being available for image formation. The advantage to this 
technology is that only a single pulse is transmitted for each line of image formed. However, 
the spectrum of transmitted frequencies overlaps with the returning harmonic signal and the 
filtering process must be carefully balanced between optimizing the harmonic signal against 
complete elimination of background tissue signal. More recent technologies have attempted to 
avoid this limitation by utilizing multiple pulse techniques. Inversion recovery is a 2-pulse 
technology that transmits sequential out-of-phase pulses and then adds the returning signal 
from each pulse (Averkiou and others 2003, Correas and others 2001). The tissue signals are 
identical and opposite and cancel each other when added together. The contrast agent signal is 
phase dependent (bubbles are resistant to compression) and the two returning agent harmonic 
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wave patterns are not mirror images and when added provide sufficient signal strength for 
image formation. This technology is used by multiple manufacturers and only suffers mildly 
from frame rate limitation of 2-signal pulse per imaging line.  
Regardless of pulse sequence utilized, the system should be optimized for both low and high 
MI studies, as clinically indicated. Contrast enhancement in most parenchymal organs is 
divided into early and late phases. The late phase is approximately up to 20 minutes after 
introduction of the contrast material and after elimination of the majority of the blood pool 
portion of contrast agent. The remaining contrast agent is described variably within the 
sinusoids or reticuloendothelial system of the liver and spleen in humans (Quaia 2005a). A 
single high MI burst sequence produces a one time static picture of contrast agent distribution 
of the remaining contrast agent (Stewart and Sidhu 2006). 
Low MI studies allow a real-time display of arteriolar perfusion and venous portions of early 
phase contrast imaging. As discussed later in the clinical applications section, the perfusion 
portion of the early phase imaging is especially important for determining the characteristic of 
liver nodules in the differential between malignant and benign nodules. 
 
2.3.6. Image analysis 
Qualitative image analysis - Contrast-enhanced color and power Doppler ultrasound 
Contrast-enhanced color and power Doppler ultrasound images may be subjectively evaluated 
for vascularity (number of vessels per unit tissue volume), distribution of vessels within a 
lesion (vascular pattern) and vessel morphology. Subjective quantification of vascularity can 
be performed by using a score. Altered vessel morphology such as stenosis, occlusion, 
trifurcations, abnormal branching patterns and loop formation may also be assessed. All the 
criteria, either in combination or alone, have been used successfully in humans to differentiate 
benign from malignant lesions in various organs for example the lymph nodes (Tschammler 
and others 2002), the breast (Schroeder and others 2003) and the musculoskeletal system 
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(Bodner and others 2002). Contrast-enhanced power Doppler ultrasound has also been proven 
useful for the evaluation of rheumatoid arthritis in humans; it was able to detect changes in 
synovial perfusion after intra-articular steroid injection and therefore, helped with the 
evaluation of synovial inflammation and the assessment of a therapeutic response (Salaffi and 
others 2004).  
Qualitative image analysis - Contrast harmonic ultrasound 
Subjective assessment of regional contrast agent distribution in either the early or late phase 
provides the basis for characterization in the majority of clinical applications (Leen and 
Horgan 2003). For previously identified nodules, masses or abnormal organs (especially 
lymph nodes), characterization of the size, shape, number and location (=vascular pattern) of 
afferent vessels provides important information. During the perfusion portion of the early 
phase regional hypoperfusion can be detected and, when compared to timing of perfusion in 
the surrounding normal tissue, is vital for characterization of malignancy. All of this is 
performed in real-time and assessed subjectively. Similarly, occult malignant nodules can be 
detected by methodical scanning through an organ during the peak of the normal tissue 
perfusion. Regional hypoperfusion can be detected in cases of infarction, thrombosis or 
necrosis by comparison to more normal regions.  
Quantitative image analysis - Contrast-enhanced color and power Doppler ultrasound 
Most manufacturers provide online image analysis packages for post-imaging quantitative 
analysis. This is especially important for research applications. Different valuable 
computerized methods have been described in the literature for the quantification of 
vascularity assessed with contrast-enhanced Doppler ultrasound in human medicine (Cheng 
and others 1999, Fleischer and others 1999, Sehgal and others 2000) as well as in veterinary 
medicine (Nyman and others 2006a, Schärz and others 2005). Basically, a region of interest 
(ROI) is applied to the image, and the percentage of colored pixels within the ROI determines 
a vascularity index indicating the percentage area of the tumor occupied by blood vessels. 
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Taking the color level of each pixel, determined by the hue, saturation and brightness values, 
into account, a measure of blood volume or perfusion within the tissue may be derived. 
Quantitative image analysis - Contrast harmonic ultrasound 
With the onset of injection of an ultrasound contrast agent, time intensity curves can be 
generated over an appropriate time by applications of ROIs to assess perfusion within tissue 
volumes or individual vessels. The following quantitative hemodynamic indices are most 
commonly obtained: peak enhancement, time to peak enhancement, up-slope, down-slope and 
area under the curve (Nyman and others 2005, Ziegler and others 2003). By this method, 
baseline data for normal organ perfusion but also disease processes can be obtained. One 
caveat for determination of these indices is accounting for respiratory motion. Regardless of 
the MI, all imaging leads to destruction of contrast agent. Movement of the liver with 
respiration presents previously nonimaged liver with naive bubbles for analysis. Estimation of 
baseline and peak values is affected by patient motion. Time to absolute peak may introduce 
too many motion and bubble integrity variables in the analysis, falsely prolonging time-to-
peak and lowering wash-in rate indices. A better method may be to calculate values of time to 
peak or indices of washout based on the times associated with 20% above baseline (as a better 
baseline value) and 90% (or other objective suboptimal value) of peak for the various indices, 
as appropriate for the organ and species (Ziegler and others 2003). 
 
2.3.7. Veterinary clinical applications 
Echocardiography - The first application of contrast ultrasound imaging was contrast-
enhanced echocardiography. Ever since the discovery of the imaging advantages of bubbles in 
shaken saline injected intravenously, bubbles have proven to be clinically valuable. The two 
major clinical indications of contrast-enhanced echocardiography are improved edge detection 
for M-mode imaging and myocardial perfusion. Perfusion assessment is especially important 
for the diagnosis of cardiac infarction in human patients. But little attention has been paid to 
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this in veterinary medicine in spite of reports of myocardial infarction with feline 
hypertrophic cardiomyopathy (Van Vleet and others 1980) and other diseases with ischemic 
changes in dogs and cats (Driehuys and others 1998). Perfusion assessment of the left 
ventricular free wall and septum can be performed in dogs and cats with the same technology 
and transducers used for abdominal imaging, although this technology is not readily available 
on echocardiography systems. 
Liver - The human liver is the most commonly studied abdominal organ for the use of 
ultrasound contrast agents. This is due to a combination of medical factors. These include the 
high prevalence and concurrent non-specific appearance of metastatic and benign nodules, 
hepatocellular carcinoma and cirrhosis in human patients. In veterinary medicine the liver is a 
very common site of metastasis of intra-abdominal primary neoplasia, especially 
hemangiosarcoma, and benign nodules are prevalent in older dogs.  
The perfusion of liver in normal dogs has been described (Nyman and others 2005, Ziegler 
and others 2003). The mean time to peak perfusion (TTP) varied from 22.9 to 46.3 seconds. 
The variability may be related to dose of contrast, agent used, injection protocol and various 
machine settings. Additional variables include patient size and age. Anecdotal evidence 
indicates that portal circulation (TTP) is faster in smaller and younger patients. Neither study 
evaluated the effects of body weight or age on time to peak perfusion. Three young dogs 
(mean age = 4 months) with portosystemic shunts had very short TTP (7 seconds) (Salwei and 
others 2003). The effect of the portosystemic shunt was not separated from the additional 
effects of disparate age and body size from the previous studies. Additional studies would be 
helpful to determine some of the effects and to isolate the arterial from portal component. 
Comparing the arterial and portal venous components of hepatic blood flow may assist with 
the diagnosis of portosystemic shunts or portal hypertension.  
The ultrasonographic diagnosis of malignancy of hepatic nodules is very challenging in small 
animals. There is no specific echo pattern for either benign or malignant nodules except 
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epithelial cysts. Nodules are commonly found in normal large older dogs, which are the same 
age and breed distribution for high risk for developing neoplastic lesions, including 
hemangiosarcoma. Detection of metastatic lesions from hemangiosarcoma by fundamental 
ultrasound is often difficult, being limited by nodule size and echogenicity, body size and 
concurrent diseases. A recent study indicated that contrast ultrasound is highly accurate for 
prediction of benign or malignant based on perfusion patterns (O'Brien and others 2004a). 
The results are similar to patterns determined for human patients with an additional pattern for 
malignant sarcoma. Benign solid regenerative nodules were isoechoic to the surrounding 
normal liver at peak normal liver perfusion. Hepatomas were more variable and had regions 
that were poorly perfused compared to surrounding liver. All malignant nodules were 
hypoechoic compared to the surrounding normal liver at peak normal liver perfusion. The 
study concluded that identification of tumor types was not possible although neuroendocrine 
tumors often had an intense rim enhancement pattern in the later portion of the early phase 
and hemangiosarcoma nodules (and some other sarcoma nodules) were very poorly perfused 
throughout the early phase with aberrant afferent vessels in the periphery of the nodule. 
Detection of small (1-2 mm) nodules was possible. A subsequent study showed improved 
detection of hemangiosarcoma hepatic nodules with detection of nodules not seen during 
grey-scale ultrasound (O’Brien, unpublished data). In at least one case the nodules seen on 
routine ultrasound were benign with contrast sonography while additional nodules, undetected 
with routine imaging, were malignant with contrast enhancement. These results demonstrate 
the utility of contrast-enhanced sonography for more accurate characterization of liver 
nodules and improved detection of malignant nodules. 
Spleen –Little has been published on contrast ultrasound of splenic lesions in dogs. Infarctions 
in the spleen, similar to other organs, are easily identified (De Morais and O'Brien 2003). At 
the time, when the present study was undertaken, there was no perfusion or vascular 
characteristic which allowed discrimination between splenic masses. Smaller solid benign and 
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malignant masses may have similar perfusion patterns as liver nodules, but this is as yet 
undetermined. However, non-invasive differentiation of malignant splenic tumors from 
hematoma or benign nodules with contrast harmonic ultrasound would represent a valuable 
method since fine needle aspirates of splenic lesions may be non-diagnostic and tissue core 
biopsies may cause further bleeding. Contrast-enhanced Doppler may be of assistance for 
characterization of thromboembolic disease of larger vessels or torsion. 
Lymph nodes - Normal lymph nodes have a primary afferent vessels which enter at the hilus, 
courses centrally and branches symmetrically along the length of the node. The 
angioarchitecture of malignant lymphomatous nodes was different from this normal pattern 
based on contrast sonography (Salwei and others 2004). In this study a high MI 
“angiographic” harmonic mode was used, although contrast-enhanced Doppler may also have 
been useful. The majority of peripheral lymphomatous nodes had aberrant vessels adjacent to 
or beneath the lymph node capsule, and deviation of the hilus.  
Pancreas - In human patients most characterization of pancreatic disease is performed by 
contrast-enhanced computed tomography; contrast harmonic imaging of the pancreas has only 
been recently performed in a few studies. There was excellent correlation between regional 
necrosis, as identified by contrast CT, and duration of hospital stay and rates of mortality in 
human patients (Balthazar 2002). In another study contrast-enhanced dynamic CT showed 
enhancement of papillary adenocarcinomas whereas ductal adenocarcinomas did not enhance 
(Oshikawa and others 2002). These results were confirmed by contrast harmonic ultrasound 
in a recent study: all ductal adenocarcinomas were hypoechoic in contrast to the hyperechoic 
papillary adenocarcinomas (Takeshima and others 2005). However, inflammatory pancreatic 
masses also present as hypoechoic lesions and they are difficult to differentiate from ductal 
adenocarcinomas (Oshikawa and others 2002).  
Contrast-enhanced color and power Doppler ultrasonography was shown a promising tool to 
assess feline pancreatic disease (Rademacher and others 2005). In comparison to normal cats, 
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vascularity and perfusion was significantly increased in cats with pancreatic diseases. 
However, whether inflammatory diseases can be differentiated from benign hyperplasia or 
neoplasia by the means of contrast-enhanced color and power Doppler ultrasonography could 
not yet be determined due to the small number of cases. Because of its depth limitations, 
contrast-enhanced color or power Doppler may not be used to assess the canine pancreas. 
Then, contrast harmonic ultrasound assessment of perfusion pattern may prove more useful.  
Kidney - Renal imaging has some interesting differences from other organs in the abdomen. 
There is a very large arterial component with faster wash-in rates and stronger enhancement 
than in the liver in the same dog (Waller and others 2001). The kidney has two capillary beds 
with the cortical region enhancing earlier than the medullary region. Lesions that have been 
detected include infarction associated with thromboembolic disease, detection of otherwise 
isoechoic lesions, and characterization of masses (Nilsson 2004). Organ rejection often results 
in poor perfusion in the transplanted kidney of human cases. Contrast ultrasound perfusion 
imaging has been shown to be on par with Technetium 99m diethylenetriamine pentaacetic 
acid (99mTc-DTPA) scans for assessment of renal perfusion (Kim and others 2005). This 
technology may have interesting application in the expanding renal transplant field in 
veterinary medicine. 
Superficial tumors - Like in humans, conventional contrast-enhanced power Doppler 
ultrasound has been shown to be more sensitive for detecting low velocities and small 
parenchymal vessels in superficial canine tumors than power Doppler alone or color Doppler 
with or without the use of a microbubble contrast agent (Schärz and others 2005). Contrast-
enhanced color and power Doppler ultrasonography has shown benefit for the differentiation 
of superficial canine and feline tumors. In a recent study in dogs, vascularity and perfusion of 
oral squamous cell carcinomas was highest, whereas it was lowest for sarcomas and moderate 
for malignant oral melanomas (Laluhova and others 2004). However, although the differences 
were highly significant, the range of values overlapped between these histological groups. 
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Therefore, the authors concluded that the biological behavior may not only vary between but 
also within the same histology group. Further, the difference in vascularity and perfusion may 
play a significant role for the prognosis of various canine cancers. Similar results were found 
in cats. Cutaneous squamous cell carcinomas were highly vascularized and perfused (Ohlerth 
and others 2006), whereas vascularity and perfusion in fibrosarcomas was very low (Ohlerth, 
unpublished data).  
 
3. Scientific objectives 
Focal lesions of the spleen are common in dogs. Differentiation between the different splenic 
lesions especially between malignant and benign changes appears crucial because it 
influences treatment and prognosis. Splenic lesions are easily detected during routine 
abdominal ultrasonography, but their appearance usually does not allow a definitive 
diagnosis. Hyperplastic nodules, hematoma, abscess, primary or metastatic neoplasia, necrosis 
from vascular compromise, toxic conditions and inflammatory disorders can produce similar 
ultrasound findings. The type of malignant splenic neoplasia cannot be determined from its 
ultrasonographic appearance. Even cavitated lesions are not pathognomonic of 
hemangiosarcoma (Nyland and others 2002a). Moreover, hyperplastic nodules are not always 
observed with B-mode ultrasonography and diffuse changes are difficult to assess. In the 
liver, for example, improved detection of hepatic metastases of hemangiosarcoma was shown 
with contrast harmonic imaging with detection of nodules not seen during grey-scale 
ultrasound (O’Brien, unpublished data). Fine needle aspirates and tissue core biopsies of 
splenic lesions may be non-diagnostic because of blood dilution and tissue core biopsies may 
not be performed in every patient because of the risk of bleeding. CT and MRI represent 
promising new diagnostic tools in veterinary medicine; however, their availability is limited, 
examinations are expensive and patients need to be in general anesthesia. Therefore, non-
invasive differentiation of malignant splenic tumors from hematoma or benign nodules with 
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contrast harmonic ultrasound would represent a valuable, cheap, easily performed and 
accessible method in veterinary medicine, similar to its use for the differentiation of liver 
lesions. Ultrasound is routinely performed in small animal medicine and widely available. 
The purpose of the present study was first, to determine normal perfusion dynamics in the 
canine spleen using contrast harmonic imaging. Second, criteria for the characterization of the 
vascular pattern and perfusion dynamics were established in clinical patients with 
cytologically or histologically confirmed splenic disease by the use of contrast harmonic 
imaging. 
 
4. Materials and methods 
4.1. Patient selection 
A prospective study was performed from January 2005 until April 2006. Three groups of dogs 
were included in the study: 1. client-owned dogs which were presented with clinical signs 
unrelated to splenic diseases and which underwent a routine abdominal ultrasound 
examination; 2. healthy dogs owned by staff members of the Small Animal Department of the 
Vetsuisse Faculty of the University of Zürich, Switzerland, who volunteered to participate in 
the study; and 3. client-owned dogs which were presented with clinical signs suspicious for 
splenic disease and in which splenic abnormalities were detected ultrasonographically during 
a routine abdominal scan. 
The study was approved by the Animal Ethics Council of the Kanton of Zürich. Owner 
consent was obtained for the contrast harmonic imaging study and fine needle aspiration of 
the spleen. Each patient underwent a physical examination. A blood analysis was undertaken 
to determine hematocrit, hemoglobin concentration and red blood cell count. Then B-mode 
ultrasound of the abdomen and finally, contrast harmonic imaging of the spleen was 
performed. 
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Spleens were considered normal if: a) conventional B-mode examination, contrast harmonic 
imaging and cytology of ultrasonographically guided fine needle aspirates of the spleen were 
unremarkable in clinically ill patients (patient group 1); or b) in clinically healthy dogs, no 
abnormalities were found with conventional B-mode and contrast harmonic imaging; 
ultrasonographically guided fine needle aspirates of the spleen were not taken in these dogs 
(patient group 2). Spleens were considered abnormal if focal or diffuse changes of the spleen 
were present with conventional B-mode ultrasound and/or contrast harmonic imaging. Then, 
lesions were confirmed with cytology of ultrasonographically guided fine needle aspirates or 
histology after surgery or necropsy (patient groups 1 and 3). Spleens were also considered 
abnormal if the conventional B-mode scan and the contrast harmonic imaging study were 
normal but cytology or histology suggested pathological changes of the spleen. 
 
4.2. Ultrasonographic imaging 
In the majority of cases, scanning of the dogs was performed using manual restraint only. 
However, uncooperative dogs or severely panting animals were sedated. After clipping and 
application of acoustic gel, a survey spleen scan was performed in every dog using 
conventional B-mode and a curvilinear array transducer at 5-8 MHz (ATL 5000, Philips AG, 
Zürich, Switzerland). For contrast harmonic imaging, a 2-5 MHz broadband curvilinear probe 
and pulse inversion harmonic imaging were used with a given machine preset (general 
imaging contrast, general). A moderate mechanical index was chosen first to depict a section 
of normal or diseased spleen as large as possible. Immediately prior to the injection of the 
contrast agent, the mechanical index was set to 0.08 while the probe remained in the same 
position. The contrast agent SonoVue (Bracco Research SA, Geneva, Switzerland) was 
administered intravenously through the cephalic vein as a rapid bolus at a dose rate of 0.03 
ml/kg. This was followed by a rapid bolus of 5 ml saline. With the onset of injection, images 
were acquired for at least 120 seconds at a rate of one frame per second for the first 20 
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seconds and then one frame per 5 seconds. Images were stored as avi-files with the extended 
loop function of the ultrasound machine and then transferred to a personal computer. For 
subjective assessment of late phase uptake in the normal spleens, the organ was imaged for 
another 3 minutes and frozen images were taken every minute. Heart rate and blood pressure 
was monitored non-invasively in every dog during contrast harmonic imaging.  
 
4.3. Image analysis 
4.3.1. Conventional B-mode ultrasonography 
The spleen was considered normal if the contours were smooth and regular, and the 
parenchyma appeared uniform, finely textured and more echogenic than the liver and the 
cortex of the left kidney (Nyland and others 2002a). Lesions of the spleen were assessed for 
their number (single, multiple), distribution (focal, diffuse), echogenicity (hypoechoic, 
hyperechoic, mixed), conspicuity (well defined, poorly defined), size, and presence of 
cavitary areas (yes, no). Presence of free abdominal fluid was also noted. 
 
4.3.2. Contrast harmonic imaging 
Subjective evaluation of the blood pool phase and late phase – In the normal spleens, images 
were assessed for the presence of an arterial and venous phase, and appearance of the 
parenchyma during the wash-in phase, peak enhancement and the wash-out phase. After the 
end of the blood pool phase spleens were also evaluated for persistent enhancement in the late 
phase up to 5 minutes after the injection of the contrast agent.  
Splenic lesions were assessed for precontrast lesion conspicuity (well defined, poorly defined, 
invisible), lesion enhancement (yes, no), enhancement pattern (homogeneous, 
inhomogeneous, special patterns), and echogenicity in comparison to the surrounding normal 
spleen during the wash-in phase, peak enhancement and wash-out phase (hypoechoic, 
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isoechoic, hyperechoic). Any additional features were noted. Lesions were also evaluated for 
persistent enhancement during the late phase. 
Quantitative computerized analysis of the blood pool phase – For this purpose, a commercial 
software program (QLAB Version 3.0, Philips AG, Zürich, Switzerland) was used. A region 
of interest (ROI), drawn as large as possible, was manually selected in every image avoiding 
inclusion of surrounding structures. A time-intensity curve was generated, and a given curve-
fit, the gamma-variate, was applied. The following parameters were recorded: total time of 
examination, time to the initial rise, average derived peak intensity (PI), time to peak intensity 
calculated from the initial rise (TTP) and the area under the curve (AUC).  
 
4.4. Statistical analysis 
Statistics were performed with a computer software program (StatView® 5.0.1, SAS Institute 
Inc., Cary, NC, USA). Level of significance was P < 0.05. 
 
5. Results 
5.1. Patients 
Twenty-four dogs were included in the study. The age ranged from 2 to 14 years (median, 6 
years; mean, 7.2 years), and body weight ranged from 6.5 to 52 kg (median, 26.4 kg; mean, 
25.6 kg). Five dogs had a body weight ≤ 15 kg: 3 Beagles, 1 Tibetian terrier and 1 Shetland 
sheep dog. Nineteen dogs of the following breeds had a body weight > 15 kg: mixed breed 
(n=9), terrier breeds (n=2), Golden Retriever (n=2), hunting dogs (n=2) and 1 Barsoi, 
Dalmatian and Belgian shepherd dog each. Eleven dogs were male and 13 female. 
Mean hematocrit was 42.4% (median, 45%; minimum, 27%; maximum, 56%; reference 
range, 42-55%), mean hemoglobin was 13.9 g/dl (median, 14.9 g/dl; minimum, 9.6 g/dl; 
maximum, 16.6 g/dl; reference range, 14.4-19.1 g/dl) and mean red blood cell count was 6.1 x 
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106/µl (median, 6.5 x 106/µl; minimum, 4.1 x 106/µl; maximum, 7.5 x 106/µl; reference range, 
6.1-8.1 x 106/µl).  
Because of motion artifacts, one dog was sedated with butorphanol (Morphasol®, Gräub AG, 
Bern, Switzerland) at a dose of 0.1 mg/kg and another animal with buprenorphin (Temgesic®, 
ESSEX Chemie AG, 6005 Luzern, Switzerland) at a dose of 10 µg/kg. At the time of contrast 
harmonic imaging, mean heart rate was 110 beats/min (median, 97 beats/min; minimum, 60 
beats/min; maximum, 168 beats/min; reference range, 60-130 beats/min). The systolic, 
diastolic, and mean arterial blood pressure at the time of contrast harmonic imaging ranged 
from 94 to 195 mmHg (median, 145 mmHg; mean, 138 mmHg), 57 to 129 mmHg (median, 
82 mmHg; mean, 86 mmHg) and 71 to 140 mmHg (median, 103 mmHg; mean, 104 mmHg; 
reference range, 60-120 mmHg). 
 
5.2. Ultrasonographic findings and pathological results 
5.2.1. Conventional B-mode ultrasonography 
Control group - Thirteen spleens were considered normal. Of these, 10 dogs (patient group 2) 
were clinically healthy and conventional B-mode examination of the spleen was 
unremarkable. Fine needle aspirates of the spleen were not available in these dogs. Three 
patients (patient group 1) suffered from diseases unrelated to the spleen (2 cutaneous mast cell 
tumors on the extremities, 1 brain tumor). Conventional B-mode examination and fine needle 
aspirates of their spleens were normal. 
Diseased group – Eleven spleens were considered abnormal based on conventional B-mode 
findings and cytology or histology (patient groups 1 and 3). Nine spleens showed hypoechoic 
lesions with conventional B-mode. Distribution, number, conspicuity, echogenicity, size, and 
presence of cavitary areas varied among the lesions (Table 1). In one dog (dog 20), an 
enlarged spleen with a typical pattern (lacy pattern) most consistent with splenic torsion was 
found with a very hypoechoic parenchyma and multiple parallel echogenic lines. The hilar 
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perivenous hyperechoic triangle was also found. A small amount of anechoic free fluid was 
seen in the same dog, whereas a moderate amount of corpuscular free fluid was diagnosed in 
one hemangiosarcoma (dog 23). Cytological, histological or surgical diagnosis was 
hemangiosarcoma (n=3), hyperplasia of lymphatic tissue (n=4), extramedullary hematopoiesis 
(n=1), malignant lymphoma (n=1) and splenic torsion (n=1). The spleen of dog 18 was 
normal ultrasonographically; however, reactive hyperplasia was found cytologically.  
 
5.2.2. Contrast harmonic imaging 
In general, contrast harmonic imaging examinations were easy to perform. Side effects of the 
contrast agent were not observed in any dog. The feasibility of the examination was rarely 
limited and included respiratory motion and general motion; therefore, two dogs had to be 
sedated.  
Subjective evaluation of the blood pool phase and late phase – Results of the subjective 
evaluation of contrast enhancement of the normal spleens (control group) were as follows: 
first, small splenic arteries radiating from the splenic hilus opacified rapidly after injection of 
the contrast agent. This was less well seen in small dogs. Subsequently, there was an 
inhomogeneous enhancement of the splenic parenchyma in all dogs. This phenomenon was 
more pronounced in some individuals than in others. Then, splenic parenchyma became 
homogeneously enhanced in every dog. Finally, a gradual decrease of opacification was 
observed. Persistent enhancement was neither seen during the blood pool phase nor during the 
late phase (Figure 1). Venous opacification was not a consistent finding and only identified in 
the hilar area.  
Results of the subjective evaluation of 11 diseased spleens with contrast harmonic imaging 
are shown in Table 2. In general, lesions, in particular small lesions, were less well defined 
with harmonic imaging prior to contrast agent application than with conventional B-mode 
ultrasound. In all benign changes of the spleen (nodular or reactive hyperplasia, 
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extramedullary hematopoiesis) lesion enhancement was seen. In all cases with nodular 
hyperplasia except one, echogenicity was isoechoic to the surrounding spleen during the 
whole blood pool phase (wash-in phase, peak enhancement and wash-out phase) (Figure 2). 
In one very large nodular hyperplasia lesion, enhancement was most prominent during the 
wash-in phase, whereas at peak enhancement echogenicity was mildly hypoechoic in 
comparison to the surrounding spleen. All three hemangiosarcomas were hypoechoic at peak 
enhancement and well delineable (Figure 3). Large aberrant vessels and displacement of 
splenic arteries were seen in two hemangiosarcomas. In the malignant lymphoma, the diffuse 
small hypoechoic lesions in the spleen diagnosed with conventional B-mode could not be 
detected with contrast harmonic imaging before and during the contrast study (Figure 4). In 
the splenic torsion, no enhancement was observed at all (Figure 5). 
Quantitative computerized analysis of the blood pool phase – Quantitative computerized 
analysis was possible in every spleen. In every normal spleen, a skewed bell-shaped curve 
was found during the blood pool phase (Figure 6). In the control group, mean baseline 
intensity was 0.55 dB (median, 0.39 dB; minimum, 0.00 dB; maximum, 2.1 dB) and mean 
intensity at the end of the blood pool phase was 2.9 dB (median, 2.24 dB; minimum, 0.75 dB; 
maximum, 7.1 dB) measured at a mean time of 142 s (median, 148 s; minimum, 99 s; 
maximum, 168 s). If the difference of the intensity at the end of the blood pool phase to 
baseline intensity was calculated, the mean was 2.34 dB (median, 1.66 dB; minimum, 0.27 
dB; maximum, 7.05 dB); the difference was highly significant (P = 0.009; 95% confidence 
interval: 1.18, 3.51; paired t-test). Time to the initial rise in the control group showed a large 
range of values (mean, 15.2 s; median, 14.5 s; minimum, 5.8 s; maximum, 24.3 s). 
For the control group, mean PI was 6.2 dB (median, 5.5 dB; minimum, 1.8 dB; maximum, 
13.9 dB), mean TTP was 23.7 s (median, 20.1 s; minimum, 5.7 s; maximum, 49.9 s) and mean 
AUC was 479.6 dBs (median, 333.7 dBs; minimum, 27.2 dBs; maximum, 1575.7 dBs). If the 
control group was split into two body weight groups (≤15 kg and >15 kg body weight), the 
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median PI, TTP and AUC were lower for the smaller dogs (4.5, 12.6 and 153.5, respectively) 
than for the larger animals (6.0, 20.7 and 336.4, respectively). However, there was a large 
overlap of the ranges and differences were statistically not yet significant (P = 0.09, 0.16 and 
0.16, respectively; Mann-Whitney U test). 
To rule out a possible influence of the varying time of examination among all dogs, the 
quantitative analysis was also performed for a defined time of examination, e.g. 90 seconds or 
100 seconds. No significant differences were found for the variables PI, TTP and AUC for the 
different examination times (paired t-test). 
There was a highly significant difference between the control group and the diseased group 
concerning age and body weight. The diseased group was significantly older and more heavy 
than the control group (P = 0.0004 and 0.004, respectively; Mann-Whitney U test). 
For the control and the diseased group, no significant association was found between the 
continuous variables hematocrit, hemoglobin concentration, red blood cell count, blood 
pressures, heart rate, age and the variables time of examination, time to the initial rise (t0), 
average derived peak intensity (PI), time to peak intensity (TTP) and area under the curve 
(AUC) (correlation analysis). There was neither a significant difference between male and 
female dogs concerning the perfusion parameters (Mann-Whitney U test). 
There was a highly significant positive correlation between AUC and PI (r = 0.96, 95% CI: 
0.9, 0.98) as well as between AUC and TTP (r = 0.7, 95% CI: 0.37, 0.87). The correlation 
between PI and TTP was moderate (r = 0.56, 95% CI: 0.15, 0.81). 
For the variables breed and sedation, a statistical analysis was not performed because of the 
low number per group. 
If the benign lesions (hyperplastic nodules, extramedullary hematopoiesis) and the 
hemangiosarcomas were compared to the control group, median PI, TTP and AUC were the 
highest for the benign lesions (11.2 dB, 29.6 s and 933.5 dBs, respectively). The 
hemangiosarcomas showed lowest TTP and AUC (8.9 s and 149.4 dBs). However, the 
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number of cases per group was small and differences were statistically not significant (P = 
0.08, 0.45 and 0.18 for PI, TTP and AUC, respectively; 1-way ANOVA and post-hoc 
Bonferroni-Dunn test).   
 
 6. Discussion 
Morphological changes of the spleen are common in the dog. Diseases of the spleen may be 
clinically suspected; however, very often, they represent incidental findings during routine 
abdominal ultrasonography. They are easily detected, but their sonographic appearance 
usually does not allow a definitive diagnosis (Nyland and others 2002a). Although the final 
diagnosis was suggested in some cases in the present study, B-mode findings such as size of 
the lesion, presence of cavitary areas within the lesion or free abdominal fluid were not 
pathognomonic. For example, the fundamental sonographic appearance of the large 
hyperplastic nodule in dog 16 (Figure 2) and the hemangiosarcoma in dog 22 (Figure 3) was 
almost identical. Moreover, with B-mode ultrasound a false-negative diagnosis may be 
formulated although focal or diffuse benign or even malignant lesions may be present 
(Nyland and others 2002a). In dog 18, the spleen was normal ultrasonographically, but 
reactive hyperplasia was diagnosed cytologically. However, up to 10%, reactive hyperplasia 
may be considered normal.  
Because of the high incidence of malignant neoplastic diseases in the canine spleen, 
differentiation especially between malignant and benign changes appears crucial because it 
influences treatment and prognosis. Ultrasound-guided fine needle aspirates or tissue core 
biopsies represent the method of choice to diagnose splenic disease. However, tissue-core 
biopsies are often avoided even by experienced specialists because of a high potential for 
hemorrhage. Lower quality samples may be attributed to red pulp congestion because of 
anesthesia or engorgement of the spleen. Aspirates and tissue-core biopsy specimens of 
complex splenic masses primarily containing fluid-filled cystic structures (e.g. 
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hemangiosarcomas) are less useful and often non-diagnostic because of blood dilution. 
Therefore, a negative aspirate does not rule out neoplasia. Moreover, repeated hemorrhages, 
necrosis, and organization may make hemangiosarcomas difficult to distinguish from 
longstanding infarction of the spleen or hematomas (Nyland and others 2002a). Whereas in 
clinically ill patients surgical excision and subsequent histological examination of the spleen 
often represent the most rational treatment, such an invasive procedure may be avoided in 
those dogs where a splenic lesion has been diagnosed incidentally. A non-invasive method 
with a high diagnostic accuracy appears a need in the diagnostic work-up of splenic diseases 
in the dog. In two recent studies, the usefulness of CT and MRI was demonstrated for the 
differentiation of benign and malignant splenic masses in the dog (Clifford and others 2004, 
Fife and others 2004). Nevertheless, the availability of these technologies is limited in 
veterinary medicine, examinations are expensive and patients need to be in general anesthesia. 
Contrast harmonic imaging represents a new ultrasonographic technology for the 
investigation of perfusion dynamics of tissue. It has been widely used in human medicine to 
classify spontaneous neoplastic lesions, mainly of the liver (Wilson and Burns 2001) but also 
of other organs, e.g. the spleen, lung and kidney (Catalano and others 2005, Gorg and others 
2006, Nilsson 2004). 
One of the goals of the present investigation was to evaluate subjectively the enhancement 
pattern of the normal canine spleen. Similar to the human spleen (Catalano and others 2005) 
small splenic arteries radiating from the splenic hilus opacified rapidly after injection of the 
contrast agent. Subsequently, there was an inhomogeneous enhancement of the splenic 
parenchyma in all dogs. This phenomenon was more pronounced in some individuals than in 
others. Then, splenic parenchyma became homogeneously enhanced in every dog. Finally, a 
gradual decrease of opacification was observed. Venous opacification was not a consistent 
finding and only identified in the hilar area. It appears important to know the normal patchy 
enhancement pattern at the beginning of the injection so that it is not wrongly interpreted as a 
 45
pathological condition. Subjectively, persistent enhancement was neither seen at the end of 
the blood pool phase nor during the late phase. However, the quantitative assessment of 
normal splenic perfusion showed that there was a significant difference of the intensity at the 
end of the blood pool phase to baseline intensity at the mean time of 142 s. We assume that 
this is most likely the result of a continuous wash-in of remaining contrast agent in the 
circulation rather than a true late phase enhancement as described in humans (Catalano and 
others 2005). In the normal human spleen, the total uptake of SonoVue did not decline after 5 
minutes, in contrast to the liver or the kidney. The mean relative uptake even increased in the 
spleen after 5 minutes (Lim and others 2004). In our control group, no plateau phase was 
observed during the blood pool phase; instead, a skewed bell-shaped curve was seen during 
the blood pool phase in every dog. Moreover, persistent enhancement was also not seen 
during the late phase. In humans, persistent enhancement of the spleen with SonoVue is 
thought to represent tissue specific properties similar to the human liver. The underlying 
mechanism is not fully understood; in the liver, accumulation may be mediated by the 
reticuloendothelial system, e.g. the Kupffer cells, or microbubbles are entrapped in the liver 
sinusoids (Quaia 2005a). According to the results of our study, no evidence of tissue 
specificity in the spleen was observed in dogs. 
In our control group, mean time to the initial rise was 15.2 s. Splenic artery opacification in 
humans is similar: 12 s (Catalano and others 2005). However, the range of the values was 
very large in our study group. Very likely, this may be due to a variable injection time with 
manual administration of the contrast agent. It may also reflect an influence of age, body 
weight, heart rate or blood pressure. However, in the present study no significant correlations 
were found. 
A possible association of body weight and the perfusion parameters PI, TTP and AUC was 
found. In small dogs, ≤15 kg, values were lower, most likely indicating that overall perfusion 
is lower and the rate of inflow is faster than in larger dogs. We assume that this is due to the 
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different circulation (higher heart rate, lower overall blood volume in small dogs). However, 
results were not yet significant and should be verified in a larger study group. Then, normal 
splenic perfusion values should be calculated with respect to body weight. 
Another purpose of the study was to investigate if perfusion patterns and dynamics differ in 
splenic lesions. Although the number of animals in the diseased group is rather low, some 
promising preliminary results were found. Subjectively, in all benign lesions (focal or diffuse) 
enhancement was observed and tissue echogenicity was iso- to mildly hypoechoic at peak 
enhancement in comparison to the normal spleen. This was in contrast to all 
hemangiosarcomas, where only very low enhancement was found. Although not yet 
significant, a similar result was found with quantitative assessment of perfusion. These results 
are similar to those found with CT (Fife and others 2004). On post contrast CT images, there 
was a significant difference in attenuation characteristics with nodular hyperplasia having the 
highest Hounsfield units, hematomas having intermediate Hounsfield units, and malignant 
masses having the lowest Hounsfield units values. The authors suggested that the low 
Hounsfield units for the hemangiosarcomas were due to the formation of large hematocysts or 
blood-filled cavities. The high degree of contrast enhancement of the hyperplastic nodules 
may have been related to the high degree of vascularity of hyperplastic lymphoid tissue. The 
underlying etiology of splenic hematomas in the dog was thought to explain the intermediate 
degree of contrast enhancement. In contrast to humans, splenic hematomas in the dog are 
often secondary to a primary disorder such as nodular hyperplasia. None of the dogs in their 
study had a history of trauma. However, the malignant masses in that study mainly included 
hemangiosarcomas and only one fibrosarcoma and one malignant fibrous histiocytoma. This 
is also a limitation of our study so far that only a few malignant splenic lesions have been 
investigated including only two different tumors. Other benign lesions such as hematomas 
were also not examined. The assessment of a larger variety of splenic diseases with contrast 
harmonic imaging will be a major goal for a future study. The results of the present study also 
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resemble the findings in the canine liver (O'Brien and others 2004a). Benign solid 
regenerative nodules were isoechoic to the surrounding normal liver at peak normal liver 
perfusion. Hepatomas were more variable and had regions that were poorly perfused 
compared to surrounding liver. All malignant nodules were hypoechoic compared to the 
surrounding normal liver at peak normal liver perfusion. Hemangiosarcoma nodules (and 
some other sarcoma nodules) were very poorly perfused throughout the early phase with 
aberrant afferent vessels in the periphery of the nodule.  
One malignant lymphoma was also examined and showed homogenous overall enhancement. 
Lymphomas have been described as well perfused and vascularized neoplasms in humans 
(Tschammler and others 2002) as well as in dogs (Nyman and others 2006b). This tumor 
group appears important to be investigated in the future because it may not be differentiated 
from the benign splenic lesions solely based on the contrast harmonic imaging findings. Then, 
a combination of ultrasonographic B-mode and contrast harmonic imaging criteria may be 
more accurate. 
No enhancement at all was observed in the splenic torsion. Although the B-mode findings 
were already highly suggestive of splenic torsion (lacy pattern, multiple parallel echogenic 
lines, hilar hyperechoic perivenous triangle, free abdominal fluid), it is well- known that these 
criteria are not pathognomonic (Mai 2006, Nyland and others 2002a). Contrast harmonic 
imaging may therefore help in diagnosing splenic torsion by diagnosing the overall absence of 
blood flow in the spleen. 
Some limitations of the present study should be discussed. Contrast harmonic imaging was 
easy to perform in every dog in the present study. However, there are some limitations of this 
technology. Due to the low mechanical index (0.08) and the low frequency range (2-5 MHz), 
overall image resolution but also resolution in the near field is dramatically reduced in 
comparison with conventional B-mode. The problem may be partially overcome, as in the 
present study, by increasing the mechanical index prior to contrast injection to localize the 
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lesion. However, in small to very small lesions, in superficial structures and in small dogs, 
these factors represent clear limitations. Recently developed probes in the medium to higher 
frequency range revealed promising preliminary results and may represent a satisfying 
solution for this problem in the future (Cosgrove 2004). 
Only in three dogs of the control group, a fine needle aspirate of the spleen was available 
confirming normal splenic tissue. Although B-mode ultrasound was normal in the other dogs, 
we cannot exclude a benign or even malignant disease. Even in the dogs with fine needle 
aspirate, a lesion could have been present in an area of the spleen other than the location 
where the sample was taken. 
The diseased group was significantly older and heavier than the control group. This is most 
likely the consequence of the higher incidence of benign and malignant splenic diseases in 
older and large breed dogs. For a better comparison, more normal and heavier dogs should be 
included in the control group in the future.  
Although no significant associations were found between perfusion and circulatory 
parameters e.g. heart rate and blood pressure in the present study, these factors appear crucial 
to be monitored during the contrast harmonic imaging procedure. Circulatory disorders may 
influence the perfusion of the normal as well as the diseased spleen. Two dogs had to be 
sedated for the sonographic examination. Drugs were used with mild cardiovascular effects; 
heart rate and blood pressure were normal in these dogs. However, in a contrast harmonic 
imaging study in the normal canine liver (Nyman and others 2005) using SonoVue, time to 
peak enhancement was significantly shorter in dogs anesthetized with propofol. Other 
perfusion parameters did not differ. Therefore, it is recommended considering the use of 
anesthetic drugs, if normal values are established. 
 In conclusion, the present study provides baseline data for the perfusion pattern and 
dynamics of the normal spleen in dogs. It may prove useful in the evaluation of dogs with 
diffuse or focal splenic disease. Preliminary results indicate subjectively or quantitatively 
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assessed differences in perfusion between normal, benign and malignant lesions of the canine 
spleen. Contrast harmonic imaging may represent a useful, non-invasive technology for the 
differentiation of splenic lesions. Further research must be done in a larger study group to 
determine the accuracy.
 50
7. References 
Albrecht, T., Blomley, M., Bolondi, L., Claudon, M., Correas, J. M., Cosgrove, D., Greiner, 
L., Jager, K., Jong, N. D., Leen, E., Lencioni, R., Lindsell, D., Martegani, A., Solbiati, 
L., Thorelius, L., Tranquart, F., Weskott, H. P. & Whittingham, T. (2004) Guidelines 
for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 25, 249-
256 
Averkiou, M., Powers, J., Skyba, D., Bruce, M. & Jensen, S. (2003) Ultrasound contrast 
imaging research. Ultrasound Q 19, 27-37 
Bahr, A., Wrigley, R. & Salman, M. (2000) Quantitative evaluation of imagent as an 
abdominal ultrasound contrast medium in dogs. Vet Radiol Ultrasound 41, 50-55 
Balthazar, E. J. (2002) Staging of acute pancreatitis. Radiol Clin North Am 40, 1199-1209 
Bauer, A. & Solbiati, L. (2003) Ultrasound contrast agents. In: Contrast-enhanced ultrasound 
of liver diseases. Eds L. Solbiati, A. Martegani, E. Leen, J. Correas, P. N. Burns and 
D. Becker. Springer, Italy. pp 21-26 
Bodner, G., Schocke, M. F., Rachbauer, F., Seppi, K., Peer, S., Fierlinger, A., Sununu, T. & 
Jaschke, W. R. (2002) Differentiation of malignant and benign musculoskeletal 
tumors: combined color and power Doppler US and spectral wave analysis. Radiology 
223, 410-416 
Bude, R. O., Rubin, J. M. & Adler, R. S. (1994) Power versus conventional color Doppler 
sonography: comparison in the depiction of normal intrarenal vasculature. Radiology 
192, 777-780 
Calliada, F., Campani, R., Bottinelli, O., Bozzini, A. & Sommaruga, M. G. (1998) Ultrasound 
contrast agents: basic principles. Eur J Radiol 27 Suppl 2, S157-160 
Catalano, O., Sandomenico, F., Matarazzo, I. & Siani, A. (2005) Contrast-enhanced 
sonography of the spleen. AJR Am J Roentgenol 184, 1150-1156 
 51
Cheng, W. F., Lee, C. N., Chu, J. S., Chen, C. A., Chen, T. M., Shau, W. Y., Hsieh, C. Y. & 
Hsieh, F. J. (1999) Vascularity index as a novel parameter for the in vivo assessment 
of angiogenesis in patients with cervical carcinoma. Cancer 85, 651-657 
Clifford, C. A., Pretorius, E. S., Weisse, C., Sorenmo, K. U., Drobatz, K. J., Siegelman, E. S. 
& Solomon, J. A. (2004) Magnetic resonance imaging of focal splenic and hepatic 
lesions in the dog. J Vet Intern Med 18, 330-338 
Correas, J. M., Bridal, L., Lesavre, A., Mejean, A., Claudon, M. & Helenon, O. (2001) 
Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. 
Eur Radiol 11, 1316-1328 
Cosgrove, D. (2004) Future prospects for SonoVue and CPS. Eur Radiol 14 Suppl 8, P116-
124 
Couto, C. G. & Hammer, A. S. (1995) Diseases of the lymph nodes and the spleen. In: 
Textbook of veterinary internal medicine, 4 edn. Eds S. J. Ettinger and E. C. Feldman. 
W.B. Saunders Company, Philadelphia. pp 1930-1946 
Couture, O., Bevan, P. D., Cherin, E., Cheung, K., Burns, P. N. & Foster, F. S. (2006) 
Investigating perfluorohexane particles with high-frequency ultrasound. Ultrasound 
Med Biol 32, 73-82 
Craig, L. E., Julian, M. E. & Ferracone, J. D. (2002) The diagnosis and prognosis of synovial 
tumors in dogs: 35 cases. Vet Pathol 39, 66-73 
Cruz-Arambulo, R., Wrigley, R. & Powers, B. (2004) Sonographic features of histiocytic 
neoplasms in the canine abdomen. Vet Radiol Ultrasound 45, 554-558 
Dalla Palma, L. & Bertolotto, M. (1999) Introduction to ultrasound contrast agents: physics 
overview. Eur Radiol 9 Suppl 3, S338-342 
Dalla Palma, L., Bertolotto, M., Quaia, E. & Locatelli, M. (1999) Detection of liver 
metastases with pulse inversion harmonic imaging: preliminary results. Eur Radiol 9 
Suppl 3, S382-387 
 52
De Morais, H. A. & O'Brien, R. T. (2003) Non-neoplastic diseases of the spleen. In: Textbook 
of veterinary internal medicine, 6 edn. Eds S. J. Ettinger and E. C. Feldman. Elsevier 
Saunders, St Louis, MO. pp 1944-1951 
Driehuys, S., Van Winkle, T. J., Sammarco, C. D. & Drobatz, K. J. (1998) Myocardial 
infarction in dogs and cats: 37 cases (1985-1994). J Am Vet Med Assoc 213, 1444-
1448 
Eriksson, R., Persson, H. W., Dymling, S. O. & Lindstrom, K. (1991) Evaluation of Doppler 
ultrasound for blood perfusion measurements. Ultrasound Med Biol 17, 445-452 
Fife, W. D., Samii, V. F., Drost, W. T., Mattoon, J. S. & Hoshaw-Woodard, S. (2004) 
Comparison between malignant and nonmalignant splenic masses in dogs using 
contrast-enhanced computed tomography. Vet Radiol Ultrasound 45, 289-297 
Fleischer, A. C., Wojcicki, W. E., Donnelly, E. F., Pickens, D. R., Thirsk, G., Thurman, G. B. 
& Hellerqvist, C. G. (1999) Quantified color Doppler sonography of tumor vascularity 
in an animal model. J Ultrasound Med 18, 547-551 
Gorg, C., Kring, R. & Bert, T. (2006) Transcutaneous contrast-enhanced sonography of 
peripheral lung lesions. AJR Am J Roentgenol 187, W420-429 
Gramiak, R. & Shah, P. M. (1968) Echocardiography of the aortic root. Invest Radiol 3, 356-
366 
Hayden, D. W., Waters, D. J., Burke, B. A. & Manivel, J. C. (1993) Disseminated malignant 
histiocytosis in a golden retriever: clinicopathologic, ultrastructural, and 
immunohistochemical findings. Vet Pathol 30, 256-264 
Jones, T. C., Hunt, R. D. & King, N. W. (1997) The hemic and lymphatic systems. In: 
Veterinary pathology, 6 edn. Eds T. C. Jones, R. D. Hunt and N. W. King. Williams 
and Wilkins, Baltimore. pp 1009-1025 
 53
Kerlin, R. L. & Hendrick, M. J. (1996) Malignant fibrous histiocytoma and malignant 
histiocytosis in the dog--convergent or divergent phenotypic differentiation? Vet 
Pathol 33, 713-716 
Kienle, R. D. & Thomas, W. P. (2002) Echocardiography. In: Small animal diagnostic 
ultrasound, 2 edn. Eds T. G. Nyland and J. S. Mattoon. WB Saunders Company, 
Philadelphia. pp 354-423 
Kim, J. H., Eun, H. W., Lee, H. J., Goo, D. E. & Choi, D. L. (2005) Clinical use of renal 
perfusion imaging by means of harmonic sonography with a microbubble contrast 
agent in patients after renal transplantation: preliminary study. Journal of Ultrasound 
in Medicine 24, 755-762 
Laluhova, D., Ohlerth, S., Wergin, M., Melzer, K., Roos, M. & Kaser-Hotz, B. (2004) 
Differentiation of spontaneous canine tumors with contrast-enhanced color and power 
Doppler ultrasound. Vet Radiol Ultrasound 45, 590 (abstract) 
Leen, E. & Horgan, P. (2003) Ultrasound contrast agents for hepatic imaging with nonlinear 
modes. Curr Probl Diagn Radiol 32, 66-87 
Lim, A. K., Patel, N., Eckersley, R. J., Taylor-Robinson, S. D., Cosgrove, D. O. & Blomley, 
M. J. (2004) Evidence for spleen-specific uptake of a microbubble contrast agent: a 
quantitative study in healthy volunteers. Radiology 231, 785-788 
Mai, W. (2006) The hilar perivenous hyperechoic triangle as a sign of acute splenic torsion in 
dogs. Vet Radiol Ultrasound 47, 487-491 
Mattoon, J. S., Penninck, D. G., Wisner, E. R., Nyland, T. G. & Auld, D. M. (2002) 
Advanced techniques and future trends. In: Small animal diagnostic ultrasound. Eds T. 
G. Nyland and J. S. Mattoon. WB Saunders Company, Philadelphia. pp 425-440 
Nilsson, A. (2004) Contrast-enhanced ultrasound of the kidneys. Eur Radiol 14 Suppl 8, 
P104-109 
 54
Nyland, T. G., Mattoon, J. S., Herrgesell, E. R. & Wisner, E. R. (2002a) Spleen. In: Small 
animal diagnostic ultrasound, 2 edn. Eds T. G. Nyland and J. S. Mattoon. WB 
Saunders Company, Philadelphia. pp 128-143 
Nyland, T. G., Mattoon, J. S., Herrgesell, E. R. & Wisner, E. R. (2002b) Ultrasound-guided 
biopsy. In: Small animal diagnostic ultrasound, 2 edn. Eds T. G. Nyland and J. S. 
Mattoon. WB Saunders Company, Philadelphia. pp 30-48 
Nyman, H. T., Kristensen, A. T., Kjelgaard-Hansen, M. & McEvoy, F. J. (2005) Contrast-
enhanced ultrasonography in normal canine liver. Evaluation of imaging and safety 
parameters. Vet Radiol Ultrasound 46, 243-250 
Nyman, H. T., Kristensen, A. T., Lee, M. H., Martinussen, T. & McEvoy, F. J. (2006a) 
Characterization of canine superficial tumors using gray-scale B mode, color flow 
mapping, and spectral doppler ultrasonography--a multivariate study. Vet Radiol 
Ultrasound 47, 192-198 
Nyman, H. T., Lee, M. H., McEvoy, F. J., Nielsen, O. L., Martinussen, T. & Kristensen, A. T. 
(2006b) Comparison of B-mode and Doppler ultrasonographic findings with 
histologic features of benign and malignant superficial lymph nodes in dogs. Am J Vet 
Res 67, 978-984 
O'Brien, R. T., Iani, M., Matheson, J., Delaney, F. & Young, K. (2004a) Contrast harmonic 
ultrasound of spontaneous liver nodules in 32 dogs. Vet Radiol Ultrasound 45, 547-
553 
O'Brien, R. T., Waller, K. R., 3rd & Osgood, T. L. (2004b) Sonographic features of drug-
induced splenic congestion. Vet Radiol Ultrasound 45, 225-227 
Ohlerth, S., Laluhova, D., Buchholz, J., Roos, M., Walt, H. & Kaser-Hotz, B. (2006) Changes 
in vascularity and blood volume as a result of photodynamic therapy can be assessed 
with power Doppler ultrasonography. Lasers Surg Med 38, 229-234 
 55
Oshikawa, O., Tanaka, S., Ioka, T., Nakaizumi, A., Hamada, Y. & Mitani, T. (2002) Dynamic 
sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J 
Roentgenol 178, 1133-1137 
Pechman, R. D. j. (1998) The liver and spleen. In: Textbook of veterinary diagnostic 
radiology, 3 edn. Ed D. E. Thrall. WB Saunders Company, Philadelphia. pp 458-466 
Phillips, P. & Gardner, E. (2004) Contrast-agent detection and quantification. Eur Radiol 14 
Suppl 8, P4-10 
Prymak, C., McKee, L. J., Goldschmidt, M. H. & Glickman, L. T. (1988) Epidemiologic, 
clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and 
splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 193, 706-712 
Quaia, E. (2005a) Classification and safety of microbubble-based contrast agents. In: Contrast 
media in ultrasonography. Ed E. Quaia. Springer, Germany. pp 3-14 
Quaia, E. (2005b) Physical basis and principles of action of microbubble-based contrast 
agents. In: Contrast media in ultrasonography. Ed E. Quaia. Springer, Germany. pp 
15-30 
Rademacher, N., Ohlerth, S., Scharf, G., Laluhova, D., Alt, N., Sieber, N., Roos, M. & Kaser-
Hotz, B. (2005) Ultrasonographic changes of the feline pancreatic architecture, 
vascularity and perfusion. Vet Radiol Ultrasound 47, 109 (abstract) 
Rubin, J. M. (1999) Power doppler. Eur Radiol 9 Suppl 3, S318-322 
Salaffi, F., Carotti, M., Manganelli, P., Filippucci, E., Giuseppetti, G. M. & Grassi, W. (2004) 
Contrast-enhanced power Doppler sonography of knee synovitis in rheumatoid 
arthritis: assessment of therapeutic response. Clin Rheumatol 23, 285-290 
Salwei, R. M., O'Brien, R. T. & Matheson, J. S. (2003) Use of contrast harmonic ultrasound 
for the diagnosis of congenital portosystemic shunts in three dogs. Vet Radiol 
Ultrasound 44, 301-305 
 56
Salwei, R. M., O'Brien, R. T. & Matheson, J. S. (2004) Characterization of lymphomatous 
lymph nodes in dogs using contrast harmonic and power Doppler ultrasound. 
Veterinary Radiology & Ultrasound 45, 274 
Saunders, H. M., Neath, P. J. & Brockman, D. J. (1998) B-mode and Doppler ultrasound 
imaging of the spleen with canine splenic torsion: a retrospective evaluation. Vet 
Radiol Ultrasound 39, 349-353 
Schärz, M., Ohlerth, S., Achermann, R., Gardelle, O., Roos, M., Saunders, H. M., Wergin, M. 
& Kaser-Hotz, B. (2005) Evaluation of quantified contrast-enhanced color and power 
Doppler ultrasonography for the assessment of vascularity and perfusion of naturally 
occurring tumors in dogs. Am J Vet Res 66, 21-29 
Schroeder, R. J., Bostanjoglo, M., Rademaker, J., Maeurer, J. & Felix, R. (2003) Role of 
power Doppler techniques and ultrasound contrast enhancement in the differential 
diagnosis of focal breast lesions. Eur Radiol 13, 68-79 
Searcy, G. P. (2001) The spleen. In: Thomson's special veterinary pathology, 3 edn. Eds M. 
D. McGavin, W. W. Carlton and J. F. Zachary. Mosby, St. Louis. pp 373-377 
Sehgal, C. M., Arger, P. H., Rowling, S. E., Conant, E. F., Reynolds, C. & Patton, J. A. 
(2000) Quantitative vascularity of breast masses by Doppler imaging: regional 
variations and diagnostic implications. J Ultrasound Med 19, 427-440 
Spangler, W. L. & Culbertson, M. R. (1992) Prevalence, type, and importance of splenic 
diseases in dogs: 1,480 cases (1985-1989). J Am Vet Med Assoc 200, 829-834 
Spangler, W. L. & Kass, P. H. (1998) Pathologic and prognostic characteristics of 
splenomegaly in dogs due to fibrohistiocytic nodules: 98 cases. Vet Pathol 35, 488-
498 
Spangler, W. L. & Kass, P. H. (1999) Splenic myeloid metaplasia, histiocytosis, and 
hypersplenism in the dog (65 cases). Vet Pathol 36, 583-593 
 57
Stewart, V. R. & Sidhu, P. S. (2006) New directions in ultrasound: microbubble contrast. Br J 
Radiol 79, 188-194 
Takeshima, K., Kumada, T., Toyoda, H., Kiriyama, S., Tanikawa, M., Ichikawa, H., Kawachi, 
T. & Ogawa, S. (2005) Comparison of IV contrast-enhanced sonography and 
histopathology of pancreatic cancer. AJR Am J Roentgenol 185, 1193-1200 
Trautwein, G. (1991) Blutbildende Organe. In: Pathologie der Haustiere, 1 edn. Eds K. 
Nieberle and P. Cohrs. Gustav Fischer Verlag, Jena. pp 93-125 
Tschammler, A., Beer, M. & Hahn, D. (2002) Differential diagnosis of lymphadenopathy: 
power Doppler vs color Doppler sonography. Eur Radiol 12, 1794-1799 
Vail, D. M. (2001) Histiocytic disorders. In: Small animal clinical oncology, 3 edn. Eds J. W. 
Stephen and E. G. MacEwen. WB Saunders Company, Philadelphia. pp 667-671 
Valli, V. E. O. (1993) The hematopoietic system. In: Pathology of domestic animals 
4edn. Eds K. V. F. Jubb, P. C. Kennedy and N. Palmer. Academic Press, Inc., San 
Diego. pp 229-237 
Van Vleet, J. F., Ferrans, V. J. & Weirich, W. E. (1980) Pathologic alterations in hypertrophic 
and congestive cardiomyopathy of cats. Am J Vet Res 41, 2037-2048 
Waller, K. R., O'Brien, R. T., Zagzebski, J. A. & Tu, H. Y. (2001) Perfusion measurements in 
the normal canine kidney following bolus injection of contrast agent. Vet Radiol 
Ultrasound 42, 586 (abstract) 
Wilson, S. R. & Burns, P. N. (2001) Liver mass evaluation with ultrasound: the impact of 
microbubble contrast agents and pulse inversion imaging. Semin Liver Dis 21, 147-
159 
Yamaya, Y., Niizeki, K., Kim, J., Entin, P., Wagner, H. & Wagner, P. D. (2004) 
Anaphylactoid response to Optison(R) and its effects on pulmonary function in two 
dogs. J Vet Med Sci 66, 1429-1432 
 58
Ziegler, L. E., O'Brien, R. T., Waller, K. R. & Zagzebski, J. A. (2003) Quantitative contrast 
harmonic ultrasound imaging of normal canine liver. Vet Radiol Ultrasound 44, 451-454
 59
8. Appendix 
Figure 1, A-G: Longitudinal images illustrating contrast enhancement of a normal spleen in a 
large breed dog (cranial is to the left, caudal to the right). 
Figure A shows a B-mode image of the normal spleen. The arrow indicates a splenic vein at 
the hilus. Figure B represents an image taken just prior to the injection of the contrast agent. 
The probe and the machine presets are chosen for contrast harmonic imaging. Again, the 
arrow indicates a splenic vein at the hilus. In Figure C, opacified splenic arteries are seen 
radiating from the splenic hilus 13 seconds after injection of the contrast agent (white arrow). 
Subsequently, there is inhomogeneous enhancement of the parenchyma (25 seconds after 
injection, Figure D). Homogeneous enhancement occurs at peak enhancement (40 seconds 
after injection, Figure E). A gradual decrease of contrast agent opacification is seen thereafter 
(120 seconds after injection, Figure F). Subjectively, persistent enhancement is not seen 
during the late phase (5 minutes after injection, Figure G).  
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Figure 2, A-E: Longitudinal images illustrating contrast enhancement in a large hyperplastic 
nodule of the spleen of dog 16 (cranial is to the left, caudal to the right). 
In Figure A, the solitary hyperplastic nodule of mixed echogenicity is marked by calipers on a 
B-mode image. Caudal to the nodule, normal splenic tissue is seen. Figure B shows the 
nodule prior to injection of the contrast agent with the contrast harmonic imaging presets. 
During the wash-in phase (Figure C), the nodule enhances well but inhomogeneous and is 
mildly hyperechoic in comparison to the surrounding spleen. At peak enhancement (Figure D) 
the nodule shows an inhomogeneous enhancement pattern and is mildly hypoechoic in 
comparison to the adjacent spleen. During the wash-out phase (Figure E) the nodule becomes 
isoechoic. 
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Figure 3, A-D:  Longitudinal images illustrating contrast enhancement in a large splenic 
hemangiosarcoma of dog 22 (cranial is to the left, caudal to the right). 
On the B-mode image (Figure A), the lesion in the tail of the spleen shows anechoic to almost 
cavitary and hyperechoic areas. Prior to contrast harmonic imaging (Figure B), the nodule 
appears inhomogeneous but cavitary areas may not be identified due to lower image 
resolution. At peak enhancement (Figure C), there is no overall uptake of the contrast agent in 
the nodule. Big aberrant vessels enhance in the center of the lesion (arrow). During the wash-
out phase (Figure D) the nodule stays mostly hypoechoic in comparison to the adjacent 
spleen; the aberrant vessels are no longer seen. 
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Figure 4, A-D: Longitudinal images illustrating contrast enhancement in a malignant 
lymphoma in the spleen of dog 21 (cranial is to the left, caudal to the right). 
On the B-mode image (Figure A) very small hypoechoic lesions are identified throughout the 
spleen. Prior to contrast agent injection (Figure B), the lesions are not detected due to lower 
image resolution. At peak enhancement (Figure C) the lymphomatous spleen shows overall 
strong enhancement. During the wash-out phase the lesions are again not seen (Figure D).  
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Figure 5, A-D: Longitudinal images illustrating contrast enhancement in a splenic torsion of 
dog 20 (cranial is to the left, caudal to the right). 
 On the B-mode image (Figure A) the spleen is markedly enlarged with diffuse anechoic areas 
and multiple parallel echogenic lines within the parenchyma. As a result of lacking blood 
flow, contrast harmonic imaging images do not show any enhancement prior to injection of 
the contrast agent (Figure B), at peak enhancement (Figure C) and during the wash-out phase 
(Figure D). 
 
 
 
 
 
 65
Figure 6: Time/intensity curve in a normal canine spleen (x-axis: time in seconds, y-axis: 
intensity in dezibel). 
The oscillating curve represents the measured values during the examination. Regular 
deflections represent breathing artifacts due to normal in- and exspiration; single larger 
deflections represent motion artifacts. A given curve-fit, the gamma-variate, has been applied 
(continuous smooth line) resulting in a skewed bell-shaped curve during the blood pool phase. 
The following calculated parameters were derived from the curve: time to the initial rise (t0), 
average derived peak intensity (PI), time to peak intensity calculated from the initial rise 
(TTP) and the area under the curve (AUC) (not shown).  
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 Table 1: Ultrasonographic findings with conventional B-mode in splenic lesions of 11 dogs 
 
No Patient Clinical Diagnosis Number, 
distribution 
Echogenicity Conspicuity Maximum 
diameter♦ 
Cavitary 
areas 
Biopsy 
Technique* 
Pathological diagnosis 
14 Mixed 
breed 
testical tumor multiple, diffuse hypoechoic/ 
patchy spleen 
poorly defined n.m. no FNA nodular hyperplasia 
15 Tibetan 
terrier 
anal gland tumor single, diffuse mixed poorly defined 1 cm yes FNA nodular hyperplasia 
16 Labrador 
Retriever 
oral fibrosarcoma single, focal mixed well defined 4.8 cm no FNA nodular hyperplasia 
17 Golden 
Retriever 
mastcell tumor multiple, diffuse hypoechoic/ 
patchy spleen 
poorly defined  n.m. no FNA reactive hyperplasia 
18 Golden 
Retriever 
brain tumor normal B-mode of spleen FNA reactive hyperplasia 
19 Hunting 
dog 
enlarged spleen multiple, diffuse mixed/ 
patchy spleen 
poorly defined n.m. no FNA extramedullary 
hematopoiesis 
20 Mixed 
breed 
weakness diffuse hypoechoic/ 
lacy pattern 
  no HISTO splenic torsion 
21 Mixed 
breed 
malignant lymphoma multiple, diffuse hypoechoic well defined ≤ 0.5 cm yes FNA malignant lymphoma 
22 Airdale 
Terrier 
fever, weakness single, focal hypoechoic well defined 4 cm no HISTO hemangiosarcoma 
23 Mixed 
breed 
collapse single, focal hypoechoic well defined 1.5 cm yes HISTO hemangiosarcoma 
24 Mixed 
breed 
fever, weakness single, focal hypoechoic well defined 2.8 cm yes HISTO hemangiosarcoma 
♦
 n.m.: not measurable 
* FNA: cytological examination after ultrasound-guided fine needle aspirate, HISTO: histological examination after surgery or necropsy 
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Table 2: Subjective evaluation of 11 diseased spleens with contrast harmonic imaging 
 
o 
 
 
Patient Pathological diagnosis 
Conventional B-mode 
appearance, 
maximum diameter* 
Precontrast 
lesion 
conspicuity 
Lesion 
enhance-
ment 
Enhancement 
pattern, 
other features 
Wash-in 
phase# 
Peak 
enhancement# 
Wash-out 
phase# 
14 Mixed 
breed 
nodular hyperplasia patchy spleen, n.m. invisible yes homogeneous isoechoic isoechoic isoechoic 
15 Tibetan 
terrier 
nodular hyperplasia mixed cavitary lesion, 
1 cm 
poorly defined yes homogeneous isoechoic isoechoic isoechoic 
16 Labrador 
Retriever 
nodular hyperplasia mixed lesion, 4.8 cm well defined yes inhomogeneous hyperechoic mildly 
hypoechoic 
isoechoic 
17 Golden 
Retriever 
reactive hyperplasia patchy spleen, n.m. invisible yes homogeneous isoechoic isoechoic isoechoic 
18 Golden 
Retriever 
reactive hyperplasia normal spleen  yes homogeneous isoechoic isoechoic isoechoic 
19 Hunting 
dog 
extramedullary 
hematopoiesis 
patchy spleen, n.m. invisible yes homogeneous isoechoic isoechoic isoechoic 
20 Mixed 
breed 
splenic torsion hypoechoic spleen, lacy 
pattern 
invisible  no  hypoechoic hypoechoic hypoechoic 
21 Mixed 
breed 
malignant lymphoma multiple hypoechoic 
lesions, ≤ 0.5 cm 
invisible no  isoechoic isoechoic isoechoic 
22 Airdale 
Terrier 
hemangiosarcoma hypoechoic lesion, 4 cm well defined yes inhomogeneous, 
large aberrant vessels 
hypoechoic hypoechoic hypoechoic 
23 Mixed 
breed 
hemangiosarcoma hypoechoic cavitary 
lesion, 1.5 cm 
well defined no  hypoechoic hypoechoic hypoechoic 
24 Mixed 
breed 
hemangiosarcoma hypoechoic cavitary 
lesion, 2.8 cm 
invisible no displaced splenic 
arteries 
isoechoic hypoechoic isoechoic 
*: n.m.: not measurable; #: echogenicity of the lesion in comparison to the surrounding spleen 
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Table 3: Results of the quantitative computerized analysis of the contrast harmonic imaging study in normal (n=13) and diseased spleens (n=11) 
 
 
Patient Group Pathological diagnosis Examination time [s] t0 [s] PI [dB] TTP [s] AUC [dB⋅s] 
1 Dalmatian 
Control group 
 
not performed 147.29 19.71 4.41 18.51 222.00 
2 Beagle not performed 146.00 17.44 5.10 12.34 170.99 
3 Beagle not performed 138.00 21.82 1.77 5.67 27.24 
4 Mixed breed not performed 148.81 6.31 6.10 20.11 333.69 
5 Mixed breed not performed 150.64 24.29 5.50 49.88 745.85 
6 Barsoi not performed 99.24 7.12 12.79 36.45 1267.76 
7 Shetland sheep dog not performed 127.56 16.28 3.92 12.76 135.91 
8 Staffordshire terrier not performed 168.40 17.13 5.98 20.70 336.44 
9 Beagle not performed 152.72 16.56 5.63 39.44 603.06 
10 Dutch shepherd dog not performed 150.59 13.76 4.12 14.84 166.05 
11 Mixed breed normal spleen 111.00 15.24 7.67 26.02 542.25 
12 Hunting dog normal spleen 153.36 16.93 4.02 9.87 107.91 
13 Mixed breed normal spleen 156.64 5.79 13.85 41.86 1575.74 
14 Mixed breed 
Diseased group 
nodular hyperplasia 108.06 12.00 13.41 32.87 1198.53 
15 Tibetan terrier nodular hyperplasia 138.89 4.22 14.06 26.36 1007.57 
16 Labrador Retriever nodular hyperplasia 155.00 7.54 29.22 35.18 2793.59 
17 Golden Retriever reactive hyperplasia 157.64 22.21 6.00 10.28 167.83 
18 Golden Retriever reactive hyperplasia 156.65 28.47 3.53 11.57 111.06 
19 Hunting dog extramedullary hematopoiesis 154.64 8.29 8.98 35.23 859.45 
20 Mixed breed splenic torsion 129.64 7.14 0.09 1.59 0.39 
21 Mixed breed malignant lymphoma 148.00 8.19 18.95 41.65 2145.49 
22 Airdale Terrier hemangiosarcoma 93.64 7.07 9.66 25.99 682.31 
23 Mixed breed hemangiosarcoma 145.94 21.56 4.57 6.88 85.36 
24 Mixed breed hemangiosarcoma 147.93 11.07 6.20 8.87 149.04 
t0: time to the initial rise; PI: average derived peak intensity; TTP: time to peak intensity calculated from the initial rise; AUC: area under the curve  
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